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This study uses Medicare claims from 1997 and 2004 to examine two 
important health policy issues using patients with ischemic stroke as an example. 
We explore the differences in rehabilitation services utilization and expenditures 
for stroke prior to and after outpatient rehabilitation caps were enacted. We then 
examine the effect of using a total cost approach versus a marginal cost method 
to estimate the first year cost of stroke and stroke rehabilitation. We found the 
cap did constrain outpatient rehabilitation utilization and cost of rehabilitation 
services if examined only using Medicare Part B provider costs, but not when 
facility costs were also included. Use of a marginal costing approach was 
superior to average costing. Indeed, the average costing approach may be 
expected to inflate the estimated 2004 SC total cost due to stroke for Medicare 
patients by $3.6 billion, because this approach ascribes expenditures for 
comorbid conditions to stroke. 
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1. INTRODUCTION 
Stroke is the third most common cause of death in the United States (US) 
and South Carolina (SC), after heart disease and cancer (CDC, 2009). Even 
more challenging, stroke is the leading cause of long-term disability (Roger, Go 
et. al., 2011 a). The American Heart Association (AHA) estimates new or 
recurrent stroke incidence in the US annually at approximately 795,000 (Roger, 
Go et. al., 2011 a). 
In 2010, it is projected that stroke related costs will reach an estimated 
73.7 billion dollars in the US alone (CDC, 2009). Hospitalization costs from stroke 
in SC were estimated at $499 million in 2008 (SC Office of Chronic Disease 
Epidemiology and Evaluation, 2009) with additional indirect costs due to lost 
productivity to be estimated at another $190 million (Mackay J., 2010). 
The National Heart, Lung and Blood Institute identified eleven US states 
(Alabama, Arkansas, Georgia, Indiana, Kentucky, Louisiana, Mississippi, North 
Carolina, South Carolina, Tennessee, and Virginia) with stroke death rates that 
were more than 100/0 higher than the US average (National Heart Lung and 
Blood Institute, 2009). Ten of the 11 states cluster in the southeastern US and 
are designated the "stroke belt" because of their higher incidence of stroke and 
stroke-related deaths (Casper, Wing et. al., 1995; Howard & Howard, 1995; 
Howard, Evans et. al., 1995). South Carolina has one of the highest stroke 
mortality rates (130 per 100,000) in the US and is considered to be a member of 
the "Stroke Belt" (SC Office of Chronic Disease Epidemiology and Evaluation, 
2009). South Carolina and specifically Charleston, lies in the "Low Country" or 
low-lying coastal plains of S.C. which has the distinction of being part of the 
"stroke buckle" where stroke rates are the highest in the nation (Howard & 
Howard, 1995). 
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Ischemic stroke accounts for 87% of all strokes, with the remaining 
strokes falling into one of the hemorrhagic categories (Benesch, Witter et. a/., 
1997; CDC, 2009). Interventions to treat acute ischemic stroke are now available 
and are increasingly being used which could effectively reduce mortality rates, 
however, long-term morbidity due to stroke-related impairments are expected to 
increase. These increases are likely to be further exacerbated by the aging 
population of baby boomers in the US 
In addition to the impact of population aging and stroke morbidity rate 
increases on stroke rehabilitation needs, governmental policy changes may also 
play an influential role in the utilization and cost of post-stroke rehabilitation. The 
federal Balanced Budget Act of 1997 (BBA 1997) included a series of changes in 
Medicare regulations aimed at cost containment. One of the regulations in the 
BBA 1997 included a $1,500 annual cap on outpatient therapy services. The cap 
included an annual limit of $1,500 in occupational therapy service expenditures 
per Medicare participant, and a $1,500 cap on combined physical and speech-
language therapy per annum, per participant. The effective date of this capitation 
program was January 1, 1999. Due to the tendency of the healthcare industry to 
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adjust to major legislation before the legislation takes effect, it is likely that, even 
in the years after the effective date where there existed a moratorium on the 
rules being enforced, outpatient rehabilitation services utilization and rehab costs 
went down even though the needs likely increased. The effect of major federal 
health care policy changes have been seen outside of effective dates in the past, 
such as with the implementation of the diagnostic related group (DRG) based 
prospective payment system in the 1980s and 1990s (Schwartz & Mendelson, 
1991 ). 
Even with Medicare's attempts to contain costs, the total cost of chronic 
illness in the US continues to rise. Some speculate that the cost of treatment 
after ischemic Stroke will increase due to the decrease in mortality and 
subsequent increase in morbidity due to trend of stroke survivors living longer 
with stroke-related disabilities. These suppositions are very difficult to confirm or 
deny due to the variability in cost of illness research models and methods. 
However, because there has been an increase in the comorbidity in the elderly 
population, an understanding of marginal cost of stroke, over and above normal 
expected medical care, is the most valuable cost benchmark to follow over time. 
Furthermore, it is important to know what proportion of post-stroke health 
services is rehabilitation-related care, both for planning purposes and to establish 
evidence that will drive future federal regulation and policy. 
Therefore, this study examined the cost of ischemic stroke in the state of South 
Carolina in order to improve our understanding of: 
1) post-stroke rehabilitation service utilization and cost changes 
between 1997 and 2004, and 
2) the 2004 marginal cost of stroke (a measure of the cost of stroke, 
over and above normal costs expected in a similar non-stroke 
population), and the proportion of marginal costs attributable to 
rehabi litation. 
Our findings will contribute to improving baseline estimates of stroke and 
rehabilitation costs as well as to inform policy decisions related to Medicare 
financing. 
AIM 1 
To examine the cost and utilization of rehabilitation services (physical 
therapy (PT), occupational therapy (OT), speech language pathology (SLP», 
before and after the 1997 Balance Budget Act. 
Rationale of Importance 
It is important to understand the effects of structural changes in 
governmental health care cost containment regulations (therapy caps) on the 
process of rehabilitation services utilization and outcome of cost. 
AIM 2 
To determine the cost of stroke-related healthcare and stroke-related 
rehabilitation care for South Carolina Medicare patients in 2004 and examine 
what proportion of the cost is rehabilitation-related. 
4 
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Rationale of Importance 
Cost of illness has been historically reported as direct total healthcare cost 
and has never been compared as a marginal cost difference with an equally ill, 
non-stroke, control group. Therefore the outcome of cost of illness has been 
historically misrepresented in a population that tends to have a great amount of 
healthcare costs that are related to comorbidities. The over-estimation caused by 
estimating cost of illness using total cost of care, results in an under-estimation of 
the impact and need for stroke rehabilitation. 
2. THEORETICAL BACKGROUND 
Stroke is a highly prevalent disease that can result in death or long-term 
debilitating impairments. Impairments can include: speech, swallowing, cognitive, 
and physical disability. At the same time some individuals experiencing a stroke 
do not survive. Studies show that stroke-related mortality appears to be on a 
downward slope, due in part to standardized treatment protocols for acute stroke 
treatment. This reduction in mortality from stroke is likely to result in an increase 
in the number of individuals with impairments requiring practitioners to transfer 
some of their research focus from acute treatment to long-term management of 
chronic stroke-related functional limitations. 
As with other common chronic diseases, such as heart disease and 
cancer, mortality rate decreases are accompanied by greater requirements for 
chronic care and attention from the patient, caregivers, and the health-care 
community as a whole. What differentiates stroke from other chronic diseases is 
the magnitude of the impact of the disease on quality of life and productivity due 
to functional impairments. 
Unfortunately society is required to assume much of the economic burden 
of stroke morbidity as many stroke survivors are over 65 years of age; and 
therefore, they receive primary healthcare support through Medicare. As more 
baby boomers reach the Medicare age range, we hope to experience what has 
been seen in this group until now, a generally healthier population. The baby 
boom generation is retiring later, or not at all, and being more productive than 
has been seen in earlier generations. This being said, the impact of post-stroke 
impairments in the baby boom generation may become an even greater burden 
on society unless advances in post-stroke rehabilitation practices and outcomes 
are realized. For these reasons it is imperative that we advance the research of 
rehabilitation which has fallen behind the multiple decades of research and 
knowledge gains in the medical management of stroke during acute care. 
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Rehabilitation professionals are striving to advance the understanding of 
which practices are best, in whom, when, and how much, without the benefit of 
knowing what is being done in the current practice of post-acute stroke care. 
There is little evidence to show how much rehabilitation stroke survivors are 
currently receiving even though clinical practice guidelines suggest a 
comprehensive team of rehabilitation specialists (physical therapists (PT), 
occupational therapists (OT), speech language pathologists (SLP), ect.) evaluate 
every individual who has survived a stroke. There is even less evidence to show 
that increases in rehabilitation contact hours results in greater productivity and 
quality of life, and less cost to society. In addition, the research community does 
not have a clear and consistent idea of the marginal cost of stroke and what 
portion of the cost is rehabilitation-related. 
This evidence is needed to help benchmark changes that we will see in 
the future as well as to help guide research to answer the all-important, "who, 
when and how much" clinical questions as well as the "at what cost to patients 
and society" policy questions. Knowing these benchmarks will also provide 
evidence to support policies that will guide how much rehabilitation care is 
supported by the healthcare payment system. Good, long-term, evidence is 
currently needed to support the expected increase in spending in the short-term 
to recover much greater savings in the longer-term while also achieving optimal 
outcomes. 
In the following sections, I will review the epidemiology of stroke and 
current mechanisms to receive and pay for rehabilitation services in the United 
States. This research was completed using South Carolina (SC) Medicare data, 
a state that bears a significant burden of stroke. I will also review current 
evidence for rehabilitation services post-stroke and I will also consider issues 
related to what is known about cost and access to rehabilitation after stroke, as 
well as the possible impact of health-care policy on clinical practice. 
2.1. Stroke Population Statistics 
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It is estimated that 7,000,000 Americans have had a stroke, indicating a 
prevalence in the population of 3% (extrapolated to 2008 from NHANES 2005-
2008 data) (Roger, Go et. al., 2011a). The AHA estimates stroke prevalence in 
the US annually at approximately 795,000, with new strokes accounting in 
610,000 of these (Roger, Go et. al., 2011a). In 2007, approximately 1 in 18 
deaths in the US were due to stroke (Roger, Go et. al., 2011a). The actual 
number of deaths from stroke fell 18.8% from 1997 to 2007 in the US (Roger, Go 
et. al., 2011 a), likely due to an increase in controlling some of the major risk 
factors. However, the reduction in mortality due to stroke may result in an 
increase in the number of individuals living with the long-term complications of 
the disease. Stroke incidence remained relatively stable in the 1990s. However, 
since then data have shown that the incidence in stroke is declining in the white 
population, but not in blacks (Roger, Go et. al., 2011a). It is estimated that every 
year 55,000 more women than men suffer from a stroke (Roger, Go et. al., 
2011 a). 
2.2. Stroke Etiology 
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Stroke is a clinical syndrome caused by a disruption of blood flow in the 
brain resulting from either a blockage in a blood vessel (ischemic stroke) or a 
rupture in a blood vessel (hemorrhagic stroke) (Mackay J., 2010). Bleeding in the 
brain (hemorrhagic), which damages surrounding tissue, or a blockage in a blood 
vessel in the brain (ischemic) which reduces blood flow, causes brain cell death 
resulting in stroke or a "brain attack". Some cells permanently die, and others are 
at risk of death, but may be saved if treated quickly (NINDS, 2011). It is 
estimated that 80-87% of all strokes are due to embolism (ischemic), 10% are 
due to intracerebral hemorrhage, and 3% are caused by subarachnoid 
hemorrhage (Demaerschalk, Hwang & Leung, 2010a; National Institutes of 
Health, NINDS, 2007; NINDS, 2011; Roger, Go et. al., 2011a; Roger, Go et. al., 
2011 a). 
Common symptoms of stroke include: sudden numbness or weakness 
particularly on one side of the body; sudden confusion or problems speaking or 
understanding speech; sudden vision impairment; sudden dizziness, trouble 
walking, or loss of balance; and/ or sudden severe headache (NINDS, 2011). In 
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many cases, more than one of these symptoms will be experienced at one time. 
Evidence suggests that the best chance to reduce permanent injury due to stroke 
is to seek medical assistance immediately (Demaerschalk, Hwang & Leung, 
2010a; NINDS, 2011). 
Incidence and mortality from stroke have declined greatly since the 1960's 
with the increased understanding and treatment of risk factors and improved 
clinical intervention for stroke (NIH - NINDS, ). However, stroke remains the 
number one cause of serious disability in adults in the US today (NINDS, 2011). 
Currently there is only one US Food and Drug Administration (FDA) 
approved treatment for ischemic stroke, intravenous infusion of recombinant 
tissue plasminogen activator (rt-PA) (Adams, del Zoppo et. al., 2007; 
Demaerschalk, Hwang & Leung, 2010a). This treatment has been shown to 
improve neurologic recovery after ischemic stroke and reduce the incidence of 
impairment and disability (Adams, del Zoppo et. al., 2007). In contrast, except for 
some surgical cases, there is no currently available clinical intervention for 
hemorrhagic stroke. In this study, I have elected to focus on ischemic stroke 
because there is current treatment for ischemic stroke and evidence suggests it 
is a likely contributor to reductions in mortality with subsequent increases in 
morbidity. 
2.3. Recurrent Stroke 
The risk of stroke also increases greatly once a person experiences a first 
stroke. Data from meta-analyses suggest that the short-term risk of recurrent 
stroke is -3-10% two days after initial stroke and 9-170/0 at 30 days after initial 
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stroke (Giles & Rothwell, 2007; Wu, McLaughlin et. al., 2007). Brown et al. found 
that 2.5% of stroke survivors will experience a second stroke within one month of 
the initial stroke, 6.60/0 will experience a second stroke within six months and 
11.8% will experience a second stroke within 12 months (Brown, Lisabeth et. al., 
2005). Despite the high likelihood of recurrent stroke, many individuals with a 
history of stroke frequently continue unhealthy lifestyles thereby increasing their 
risk of recurrent stroke (Cheng, Jolly et. al., 2005; Hoenig, Nusbaum & Brummel-
Smith, 1997; Qureshi, Suri et. al., 2001). 
2.4. Stroke Risk Factors 
The major risk factors associated with stroke include: high blood pressure, 
atrial fibrillation, high cholesterol, smoking, poor diet, obesity, family history, lack 
of exercise, diabetes, and age (Mackay J., 2010; NINDS, 2011). Risk factors for 
stroke include both modifiable and non-modifiable factors. Non-modifiable risk 
factors which cannot be changed by an individual include gender, with women 
having a higher lifetime risk of stroke than men, due mostly to their longer life 
expectancy. An additional non-modifiable risk factor is age. The risk of having a 
stroke increases greatly with age. Another is race, with minorities having higher 
risk of stroke. An individuals' risk of having a stroke also increases if they have 
recently experienced a transient ischemic attack (TIA) (Roger, Go et. al., 2011 a). 
Individuals with a history of TIA have a 10 year risk of stroke of -20% (Clark, 
Murphy & Rothwell, 2003). 
Additional risk factors for stroke that are non-modifiable but in themselves 
may be modifiable with behavioral changes or medication use include: increased 
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risk if a person has a history of congestive heart disease, heart failure, peripheral 
artery disease, hypertension, diabetes, atrial fibrillation, sickle cell disease, and 
dyslipidemia (Roger, Go et. al., 2011 a). The list of modifiable risk factors is 
similar to risk factors for other chronic diseases. They include obesity, smoking, 
and physical inactivity (Roger, Go et. al., 2011 a). Of these risk factors, having 
recently had a TIA, having high blood pressure (hypertension) or having atrial 
fibrillation has been shown to carry the greatest increased risk for stroke (Roger, 
Go et. al., 2011 a). Stroke risk factors become comorbidities which contribute to 
long and short term negative outcomes and cost of care for individuals with 
stroke. 
2.5. Stroke Mortality 
In a study of people ~ 65 years of age from Medicare data, the 1-month 
case fatality rate was 12.6% for all strokes, 8.1% for ischemic, and 44.60/0 for 
hemorrhagic (Roger, Go et. al., 2011 a). Mortality rates due to stroke are higher in 
women than men, and in blacks versus whites while risk of stroke increases with 
age (Roger, Go et. al., 2011 a). When compared with the Northeastern US, the 
crude and age-standardized total and ischemic stroke death incidence rates are 
higher in the Southeast and Midwest (Roger, Go et. al., 2011a). 
2.6. Stroke Impairment and Disability 
The US National Institutes of Health (NIH) estimates that 10% of people 
recover almost completely after stroke, 25% recover with mild impairment, 40% 
live with moderate to severe disability requiring special care, 10% are disabled 
enough to require long-term institutionalization, and 15% die shortly after having 
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stroke (National Institutes of Health, NINDS, 2007). This equates to over 65% of 
stroke sufferers needing specialized stroke-related rehabilitation services. The 
need for these services increase costs in individuals with stroke. 
The World Health Organization (WHO) in collaboration with the Center for 
Disease Control (CDC) publishes data related to the impact of stroke on disability 
adjusted life years (DAL YS). In these publications they define DAL YS as the 
"combined years of potential life lost due to premature death with years of 
productive life lost due to disability" (Mackay J., 2010). In the most recently 
published version of the CDC and WHO's combined report entitled "The Atlas of 
Heart Disease and Stroke", it is estimate that 8 DAL YS per 1000 population in 
the US are lost due to stroke (Mackay J., 2010). 
According to the AHA, based on 2005 Behavioral Risk Factor Surveillance 
System (BRFSS) data only 30.70/0 of those surviving a stroke receive outpatient 
rehabilitation services. The authors of this AHA report entitled, "Heart Disease 
and stroke Statitistics - 2011 Update" suggest that these 2005 findings indicated 
that, 
"the prevalence of stroke survivors receiving outpatient 
stroke rehabilitation was lower than would be expected if 
clinical practice guideline recommendations for all stroke 
patients had been followed" (Roger, Go et. al., 2011 a). 
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In a 2003 study of ischemic stroke survivors who were ~ 65 years of age 
(based on Framingham Study data) there are a number of disabilities commonly 
seen after stroke. This study found that at 6 months following ischemic stroke, 
500/0 of their sample had some amount of hemiparesis, 460/0 experienced 
cognitive deficits, 35% had symptoms of depression, 30% were unable to walk 
unassisted, 260/0 were dependent in activities of daily living (ADLs: Barthel < 60), 
26% were institutionalized in a nursing home, 19% had aphasia, and 15% had 
sensory deficits (Kelly-Hayes, Beiser et. al., 2003). All of these proportions were 
shown to be clinically and statistically significantly greater than seen in a control 
group, indicating a need for long-term rehabilitation therapy to address these 
deficits and improve symptoms. 
2.7. Cost of Stroke in the US 
In 2010, it is projected that stroke related costs will reach an estimated 
$73.7 billion in the US alone (CDC, 2009). The AHA estimates total stroke costs 
in 2007 dollars (from Medical Expenditure Panel Survey (MEPS) data) at $40.9 
billion (Roger, Go et. al., 2011 a). The variation between the Centers for Disease 
Control (CDC) and AHA estimates, even with a time differential of three years, is 
extremely broad. According to the Rochester Stroke Study, the thirty day post-
event cost of a mild versus severe ischemic stroke was estimated at $13,019 and 
$20,346, respectively (data was from between 1987 and 1989 and severity was 
based on Rankin Scores) (Roger, Go et. al., 2011 a). These studies highlight the 
need for more consistent and accurate estimates of costs of illness. These cost 
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estimates also did not differentiate between stroke-related costs with that of care 
for unrelated illnesses. 
2.8. Stroke in South Carolina Stroke Belt 
Since the 1940s there has been a significant geographic disparity in stroke 
mortality in the US, with higher rates seen in the southeast. This area is referred 
to as the "stroke belt". The National Heart, Lung and Blood Institute (NHLBI) 
identified eleven US states (Alabama, Arkansas, Georgia, Indiana, Kentucky, 
Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Virginia) 
with stroke death rates that were estimated at 10-200/0 higher than the US 
average (National Heart Lung and Blood Institute, 2009; Roger, Go et. al., 
2011 a). Ten of the 11 states cluster in the southeastern US ,and are designated 
the "stroke belt" because of their higher incidence of stroke and stroke-related 
deaths (Casper, Wing et. a/., 1995; Howard & Howard, 1995; Howard, Evans et. 
a/., 1995). The AHA lists only eight states to be members of the stroke belt, 
including North Carolina, South Carolina, Georgia, Tennessee, Mississippi, 
Alabama, Louisiana, and Arkansas (Figure 2-1.) (Roger, Go et. al., 2011a). 
South Carolina has one of the highest stroke mortality rates (130 per 
100,000) in the US and is considered to be a member of the Stroke Belt (SC 
Office of Chronic Disease Epidemiology and Evaluation, 2009). South Carolina 
and specifically Charleston, lies in the "Low Country" or low-lying coastal plains 
of SC which has the distinction of being part of the "stroke buckle" where stroke 
rates are the highest in the US (Howard & Howard, 1995). Other states included 
in the stroke buckle are North Carolina and Georgia. The mortality rate from 
16 
stroke in this region is estimated to be 400/0 higher than in the US in general 
(Howard & Howard, 1995). Also notable is a recently published report that 
indicates that South Carolina is one of 15 different states that has been defined 
as the "diabetes belt" where approximately 12% of residents have diabetes 
compared to 8.5% of the rest of the population (Barker, Kirtland et. al., 2011). 
Diabetes is a major risk factor for stroke. 
Figure 2-1.Age-adjusted Stroke Death Rates by State (Roger, Go et. al., 2011 a). 
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2.9. Rehabilitation for Stroke 
Puerto Rico 
Post-stroke rehabilitation services are needed to help improve functional 
limitations caused by debilitating illness. However, the timing and amount of 
services that are needed and for which population groups is not well understood. 
Nor is there a good understanding of what is being done in current practice and 
how much the current practice of rehabilitation after stroke is costing insurers and 
society as a whole. Quantifying current practice patterns and economic cost of 
rehabilitation care is essential in order to tackle the questions of "who, what, 
when, and how much is optimal" and for which patients. Without a baseline of 
current post-stroke rehabilitation practice patterns and an understanding of 
variability in care, the direction that research needs to take to support evidence 
based practice in rehabilitation science is unknown. 
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Rehabilitation use in stroke is an important and complex issue because it 
affects both health and costs in a interactive manner. Current rehabilitation 
practices are well described in an article by Conroy and colleagues entitled, 
"Hospital-Based Stroke Rehabilitation in the United States" (Conroy, Dejong & 
Horn, 2009). Once stroke patients have stabilized during acute hospitalization, 
they are usually discharged either to home where they often get either home-
based or outpatient rehabilitation services, to a skilled nursing facility (SNF), also 
traditionally known as a nursing home, if they need more around-the-clock 
nursing care, or most commonly to an inpatient rehabilitation facility (IRF) 
(Conroy, Dejong & Horn, 2009). Each of these options will allow for a mix of 
standard rehabilitation services including, physical therapy (PT), occupational 
therapy (aT), or speech language pathology therapy (SLP). 
Conroyet. al. indicates the driver of rules for rehabilitation after stroke is 
Medicare, because stroke is a low incidence disease that primarily occurs in the 
elderly. Since Medicare is the main mechanism funding healthcare for seniors 
and the disabled, it covers most people who have suffered a stroke (Conroy, 
Dejong & Horn, 2009). Furthermore, rules set by Medicare, both for clinical as 
well as time-line and financial requirements are usually adopted by other 
insurers. 
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The paper by Conroy and colleagues emphasizes the post-acute 
rehabilitation practices in IRFs. The average length of stay in an IRF is 15 days, 
with 70% of stroke patients being discharged home after their stay and 30% 
returning to acute care settings or to SNFs (Conroy, DeJong & Horn, 2009). 
SNFs generally provide 24 hour nursing care and 1 to 1.5 hours of PT, OT, 
and/or SLP therapy Monday through Friday. Medicare only pays for the first 100 
days in a SNF, after which, if additional care is needed, the individual is either 
switched to Medicaid or private insurance whom Conroy notes do not generally 
cover rehabilitation services. 
According to the rules of Medicare, an individual who has had a stroke 
and is in an acute care setting would be evaluated based on the "3 hour rule" for 
admission to an IRF. Under this rule, a patient has to either already be able to 
tolerate 3 hours of therapy (consisting of OT, PT, or SLP) a day or will soon 
reach that level of ability in order for the patient to be considered for transfer to 
an IRF. The rules for admission to an IRF and rehabilitation requirements once in 
an IRF are significant, resulting in limited access due to perception of need, 
chances for improvement, and likelihood of discharge to home. 
2.10. Evidence for Rehabilitation Services Effectiveness 
A consensus group from the American Heart Association published a set 
of comprehensive guidelines outlining recommendations for evidence based 
acute and post-acute stroke rehabilitation suggested that the strongest evidence 
exists to support the use of a well-organized, multidisciplinary team approach to 
post-stroke rehabilitation care (Duncan, Zorowitz et. al., 2005). They also 
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recommended that rehabilitation be started by the patient as soon as was 
medically possible or "early intervention" to facilitate positive outcomes. Although 
this group indicated a lack of consistency in defining or testing what "early 
intervention" really means. They commented that "current literature is too limited 
to allow an assessment of the relationship of specific types of non-inpatient 
rehabilitation services after stroke and functional outcome" (Duncan, Zorowitz et. 
a/., 2005). 
The AHA consensus group gave a series of recommendations for 
practices that have been shown to improve a standard set of outcomes, 
including: functional status (including the FIM, ADLs and IADLs), re-
hospitalization rates, community dwelling status, and mortality (Duncan, Zorowitz 
et. a/., 2005). In addition to the strong recommendation to offer all stroke patients 
organized, multidisciplinary team-oriented stroke unit care, the group gave many 
more specific recommendations. The guidelines included, utilization of the 
National Institutes of Health Stroke Scale (NIHSS) to assess stroke severity over 
multiple occasions, provision of early initiation of rehabilitation therapy, use of 
subcutaneous low-dose unfractionated heparin to prevent DVT/PE for patient 
with ischemic stroke and impaired mobility, assessment of all patients for 
swallowing (dysphagia) impairments, evaluation of all patients for proper nutrition 
and hydration, assessment of pain, assessment of all patients for cognitive and 
communication impairments, assessment of all patients for psychosocial 
problems particularly depression, assessment of all patients for ADLs and IADLs 
prior to discharge from acute settings, access to long term rehabilitation care for 
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patients where need is indicated except for where poor prognosis for functional 
recovery suggest discharge to SNF is preferable (Duncan, Zorowitz et. a/., 2005). 
A second group published a recommendation for best post-acute stroke 
rehabilitation upon reviewing the structure, process, and outcomes comparing 
different international systems of care (Donabedian, 1988; Teasell, Meyer et. al., 
2009). Teasell and colleagues noted that structures of care, such as use of 
specialized interdisciplinary stroke rehabilitation units and outpatient care 
programs have been shown to impact the process of care, but not stroke 
outcomes directly (Teasell, Meyer et. al., 2009). They indicate that there is good 
evidence supporting the direct influence of processes of care on stroke outcomes 
related to changes in Functional Independence Measurement (FIM) scores, 
Length of Stays (LOS), mortality, and discharge destinations. They used the 
comparison between westernized countries as a mechanism to differentiate 
which process differences may positively or negatively impact overall outcomes, 
a similar method as is used in studies of small area variation, but on a large 
system scale. 
The four processes that were specifically highlighted by this group are: 1) 
early time to admission into a stroke rehabilitation unit or program, 2) intensity of 
therapy over a shorter time period performing beUer than less intense therapy 
over a greater time period, 3) utilization of task-specific therapy being superior to 
restorative therapy, and 4) discharge planning being key to improved Activities of 
, 
Daily Living (ADL) and patient satisfaction, particularly early supported discharge 
programs (ESD) for patients who have had mild to moderate strokes (Fisher, 
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Gaynor et. a/., 2011; Teasell, Meyer et. a/., 2009). Rehabilitation for individuals 
with stroke has the potential to mediate costs due to stroke in the long term. 
However this might necessitate an increase in therapy utilization and intensity of 
treatment which may require increases in spending in the short term to gain 
savings in the longer-term. 
2.11. The Economics and Utilization of Rehabilitation after Stroke 
Stroke imposes a considerable economic burden on the US healthcare 
system, particularly ischemic stroke which accounts for 870/0 of stroke 
(Demaerschalk, Hwang & Leung, 2010b). In 2010, it was projected that stroke 
related costs would reach an estimated $73.7 billion in the US alone (CDC, 
2009), which is a significant increase from the 2008 estimate of $65.5 billion 
(Adams, del Zoppo et. a/., 2007). Hospitalization costs from stroke in SC were 
estimated at $499 million in 2008 (SC Office of Chronic Disease Epidemiology 
and Evaluation, 2009) with additional indirect costs due to lost productivity to be 
estimated at another $190 million (Mackay J., 2010). 
Healthcare costs continue to rise and are becoming a larger portion of the 
national gross domestic product. These costs have become a burden on the 
overall economic wellbeing of the nation resulting in more governmental policies 
aimed at healthcare cost-containment. The problem with these policies is their 
intent may not result in savings but in greater cost burdens in the longer-term as 
well as reductions in the quality of care. In a healthcare system as complicated 
as what we have in the US, anyone change can have many unforeseen 
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consequences that are often not understood until a significant negative impact is 
felt. 
2.11.1. Cost of Stroke Rehabilitation 
Previous studies estimating the cost of stroke have reported widely 
varying results. Costs likely differ depending on many factors, including the 
amount of rehab care given. Factors that may influence hospital length of stay 
and consequently cost of stroke include the type of stroke, stroke severity, and 
unmeasured comorbid conditions related to overall health status. What is missing 
from this literature entirely is an examination of the cost-effectiveness of different 
types of post-acute rehab care. This type of analysis can tie in the pragmatic cost 
with patient outcomes. This research is missing because the research community 
must reach a point of understanding how "gold-standard" post-stroke 
rehabilitation care is defined. Only then can different therapies be compared in 
their pragmatic cost-effectiveness to society. It is this great unknown in post-
acute stroke care that is limiting the direction of research to improve long-term 
outcomes in this population. 
Post-acute care (PAC) settings include inpatient rehabilitation facilities 
(IRFs), skilled nursing facilities (SNFs), home-based healthcare services from 
home health agencies (HHA), and hospital-based outpatient rehabilitation 
services (ORS). Medicare spending for post-acute care was estimated to 
encompass 15% of all Medicare spending in 2008 (Medicare Payment Advisory 
Commission (MedPAC), 2008). According to a study by Buntin et. al. on the cost 
and outcomes of post-acute care in Medicare patients after stroke, the cost of 
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IRF care after stroke is on average $10,121 per episode higher than SNF care 
and $24,219 per episode higher than home-based care (Buntin, Colla et. al., 
2010). These authors also found that IRF care resulted in reduced mortality and 
SNF care resulted in increased long-term institutionalization after stroke (Buntin, 
Colla et. al., 2010). Therefore, while a number of studies have concluded that 
IRF care after stroke leads to better outcomes, these gains come at a 
considerably higher cost. 
It is unclear if these gains are figments of differences due to disease 
severity and if these "proxy outcomes" can be directly related to functional 
improvements that are of primary concern in this population. It could be true that 
more severely disabled patients with the greatest chance for gains are most likely 
to get IRF care and more disability means greater room for improvement. It is 
easier to measure the impact of acute in outcomes like length of stay, mortality 
status, and discharge disposition. Post-acute outcomes tend to be more difficult 
to measure especially in larger populations and over long time periods. It is also 
important to separate out the cost of acute care from the cost of post-acute 
rehabilitation services. A more complete baseline view of utilization and cost will 
help to drive the direction of research needed to help answer some of these 
deeper, clinically relevant questions. 
2.11.2. Stroke Rehabilitation Utilization 
Post-acute care (PAC) includes a wide range of healthcare services that 
aim to restore recently hospitalized patients to the highest level of functioning 
possible and generally involves rehabilitation. It is estimated that 70% of stroke 
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patients use PAC services after acute hospital discharge (Buntin, 2007). 
Depending on clinical presentation and/or perception of need and ability to 
benefit from PAC, medically complicated patients are discharged to IRFs, 
patients with age-related cognitive impairments tend to be discharged to SNFs, 
and healthier patients or in some cases patients unable to endure intensive 
rehabilitation schedules tend to be discharged home after acute stroke 
hospitalization (Buntin, 2007). When patients are discharged from inpatient 
stroke care they mayor may not receive additional outpatient rehabilitation 
services. Thus, the cost of outpatient rehabilitation services will greatly depend 
on prior use of inpatient care and patient's perceived ability to benefit from 
rehabilitation services. If no outpatient care is received resulting in immediate 
cost savings, long-term residual disability may remain creating greater personal 
and societal economic burden. 
It is understandable and expected that many clinical factors have an effect 
on use of post-acute care services. However, due to the lack of and depth of 
clinical research indicating which patient groups would benefit most from PACs 
including which types, time frames, and intenSity of services benefits particular 
patient groups, many non-clinical factors likely influence who utilizes PAC after 
stroke (Buntin, 2007). Studies on access and use have shown that geographic 
distance to PAC services strongly influence use, and sex, race, and ethnicity 
differentially influence utilization of PACs in stroke populations (Buntin, 2007). 
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2.12. The Impact of Healthcare Policy on Stroke 
The aforementioned non-clinical influences on the utilization of PACs after 
stroke, along with the lack of evidence on the appropriate trajectory of care after 
an acute event such as stroke, have led many healthcare policy observers to fear 
differential access to PACs. It is also possible that other financial factors 
including changes to Medicare payment structures may be influencing access 
(Buntin, 2007). Buntin and colleagues provide evidence that support these fears, 
by illustrating greatly varying use of IRFs, SNFs, and HHAs between 1997 and 
2002 in the US which was a time of changing Medicare reimbursement policies 
that included the advent of the prospective payment system (PPS). What does 
appear evident is that no matter what the intent of changes to payment policies, 
there are always unintended consequences. 
Besides the impact of the Medicare PPS on PAC facility usage, which 
some suggest was short lived and simply shifted care between different types of 
facilities (Buntin, 2007), the federal US Balanced Budget Act of 1997 (BBA 1997) 
implemented a cap on outpatient rehabilitation services. The BBA 1997 included 
a series of changes in Medicare regulations aimed at cost containment including 
a $1,500 annual cap on outpatient therapy services. The cap included an annual 
limit of $1 ,500 in occupational therapy service expenditures per Medicare 
participant, and a $1,500 cap on combined physical and speech-language 
therapy per annum, per participant. These amounts were increased in 
subsequent years to reflect inflation. While the original effective date of these 
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caps was January 1, 1999, the caps have rarely been in effect or enforced (Table 
2-1 ). 
T bl 2 1 R a e - I t' T· I' egu a Ion Ime Ine 0 f 0 t t' t R h bTt t' C u:ga len e a II a Ion aps 
Year Capitation Outcome Amount 
1998 - Law not yet in effect 
1999 $1,500 Implemented but under litigation (not 
enforced) 
2000 - Under Moratorium 
2001 - Under Moratorium 
2002 - Under Moratorium 
2003 $1,590 Effective from September - December 
2004 - Under Moratorium 
2005 - Under Moratorium 
2006 $1,740 Applied with Exceptions* 
2007 $1,780 Applied with Exceptions* 
2009 $1,810 Applied with Exceptions* 
2008 $1,810 Applied with Exceptions* 
2010 $1,860 Applied with Exceptions* 
2011 $1,870 Applied with Exceptions* 
*Exceptions automatic if a complex condition, other conditions require manual requests 
Even though the enforcement of the outpatient rehabilitation services caps 
has been in flux since the passage of the BBA 1997, the policy change may have 
produced a structural change within the outpatient rehabilitation community in 
regards to the amount of hours of services commonly rendered. The influence of 
a policy prior to enforcement may be due to the tendency of the healthcare 
industry to adjust to major legislation before the legislation takes effect, because 
the healthcare system decision-makers anticipate legislative changes and 
respond proactively (Schwartz & Mendelson, 1991). This research predicts that 
outpatient rehabilitation services utilization and rehabilitation costs went down 
after the outpatient rehab caps date, even though beneficiary needs likely 
increased. The effect of major federal health care policy changes have been 
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seen outside of effective dates in the past, such as with the implementation of the 
DRG based prospective payment system in the 1980s and 1990s (Schwartz & 
Mendelson, 1991). 
2.13. Rehabilitation and Health Services Research 
Theoretical models that describe and outline the process of disability 
caused by injury or illness allow scientists and clinicians a systematic means to 
communicate within and between disciplines. They also allow for greater directed 
inquiry into causes of disability and methods to illicit rehabilitation from those 
disabilities, as well as into the contributing factors that influence both of these 
processes. Over time, models to describe the disease process have changed 
and developed as health care practice has advanced and become more 
complex. These changes include the potential of system-wide policy changes 
and their cost implications as factors that may influence clinical and quality of life 
outcomes even though they are external to the patient. The study of the long 
term effects of stroke and their cost ramifications would benefit greatly from the 
perspectives gained through theoretical modeling. 
One of the earliest models that continue to drive health care research 
today, "the medical model" includes the central theme of the patient as the 
problem, with the central goal to cure the individual. Later rehabilitation models 
began to expand on earlier thinking to include personal and societal influences 
on health. An early rehabilitation model posed by Nagi expanded the medical 
model to include the thinking that biological changes can lead to impairments 
which may lead to functional limitations possibly causing disability (NAGI, 1964). 
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Today the rehabilitation model that most researchers agree has the most 
applicable themes allowing for the complexities of human health is the 
International Classification of Functioning, Disability and Health (ICF). The ICF 
allows for multi-directional movement between problems on the functional and 
body structure level affecting activity which may influence participation. This 
model also accounts for the possibility that each of these stages can be affected 
by the outside influences of personal characteristics and environmental factors. 
Environmental factors can include governmental or system-wide rules on cost 
structure. 
In order to expand the medical or rehabilitation models that drive health 
care research to find solutions on the individual patient level, to the idea that 
population health may be affected by even more outside factors, we can utilize 
health services research models to direct structural or process level questions. In 
the late 1980s and early 1990s, Avedis Donabedian produced a theoretical 
Health Services Research (HSR) model on the relationship between health care 
structures, processes, and outcomes (Donabedian, 1988). Structure refers to all 
factors that may influence the physical environment or setting of health care 
delivery, such as policies and procedures, rules and regulations, buildings and 
equipment, and standards for performing interventions. This can range from how 
hospital facilities are laid out, to who is available at all times on a stroke team, to 
reimbursement practices. Process relates to how care is provided. Process 
includes effects of factors such as treatment guidelines, how a referral process is 
coordinated, the timing of hospitals' discharge of patients to home care or to 
29 
other post-acute care settings, the type of therapy provided or how much therapy 
is given. Lastly, outcomes refer to how endpoints of care are measured, 
evaluated, and quantified, which may include patient preferences. Outcomes 
refer to both intermediate and ultimate outcomes. Intermediate outcomes include 
factors related to resource consumption such as cost, length of stay, or 
consumption of specific services. Ultimate outcomes are measures such as 
survival, quality of life, and health status. The model proposed by Donabedian is 
especially useful for organizing factors that related to a "health production" 
function, where the focus is on better understanding the effects of structural 
constraints, such as regulation, on the utilization of scarce resources, and on 
both intermediate and ultimate population outcomes. This model is not as well 
suited if the outcomes of interest are related to individual patients, but it is very 
accommodating of policy questions. 
This research project used the Donabedian "Structure-Process-Outcome" 
HSR model as a framework for examining the effect of outpatient rehabilitation 
caps on the use of PT, OT, and SLP healthcare services (aim 1). The cap placed 
on outpatient rehabilitation services under the BBA of 1997 forces a process 
change in the care of patients with stroke. Legislative reimbursements limits fit 
the Donabedian model as a structure effect which may be expected to affect the 
process of rehabilitation care. This process change will affect the outcome 
measured as healthcare cost and also other outcomes such as quality of life 
which is not examined in the proposed research. The theoretical framework that 
guided this research study is depicted in Figure 2-2 below. 












Structural changes in rehabilitation practices prompted by the Medicare 
reimbursement policy that occurred via the BBA of 1997 with the onset of 
outpatient rehabilitation caps fits well into Donabedian's paradigm that 
operationalizes constraints on practice settings in the healthcare system and 
their effect on the process of care. If rehabilitation practitioners expect to have 
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limits on the reimbursement for the amount of care that they can administer to a 
Medicare beneficiary, it is conceivable that these limits may precipitate a change 
in the process of care, including a decrease in average rehab utilization. 
Additionally, if utilization is reduced due to changes in the process this may 
similarly affect the cost of care which is an economic outcome under the 
Donabedian model. 
2.14. Summary 
Stroke is a serious, prevalent, disease that is costly to society. Since 
stroke mortality is decreasing across the US but individuals are living longer after 
stroke, it is reasonable to conclude that long-term morbidity due to stroke is likely 
to increase, especially in SC where stroke incidence is high. With increases in 
people suffering from the long-term effects of stroke, quantifying rehabilitation 
services costs and utilization will help policymakers to plan for future needs and 
will begin to progress our understanding of best rehabilitation practices and 
future research needs. 
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Studies examining rehabilitatjon services utilization can benefit from the 
use of theoretical rehabilitation and health services models. These models can 
help to outline how structural changes in the healthcare system may influence 
processes and in turn healthcare outcomes. Federal regulatory caps on Medicare 
reimbursement of rehabilitation services are structural changes that may have an 
effect on health services utilization which lies in the area of process of care. The 
change in the amount of rehabilitation services received by an individual may, in 
turn, affect the cost of care, an economic outcome. In this study theoretical 
models were used to map the potential impact of the SSA of 1997 on 
rehabilitation services utilization and the related impact on the outcome of stroke 
and rehabilitation costs in the year after acute ischemic stroke. 
3. METHODOLOGICAL BACKGROUND 
It is important to recognize the type of health services research completed 
in this project requires a specialized set of methodological approaches in order to 
be performed in a reasonable and reliable manner. Challenges related to the 
retrospective analysis of long-term administrative billing data include difficulty 
specifying diagnoses, procedures, comorbidities, and disease severity. 
3.1. Research Using Administrative Data 
Administrative data, also known as billing data or archival data, are 
commonly used in research to examine health related questions. These data are 
readily available, inexpensive to obtain, available in a computer-readable 
database format, and cover large populations over long periods of time (Iezzoni, 
1997; lezzoni, 1994; Mitchell, Bubolz et. a/., 1994; Zhan & Miller, 2003). 
The utility of administrative claims data for the evaluation of health care 
services and outcomes has been well established. Over the past 30 years, the 
analysis of retrospective administrative data has been used to examine practice 
variation (Wennberg et al. 1989; Shwartz, Ash et. al., 1994), determine 
differences in access to care in minority groups (Desch et al. 1996), assess 
quality of care metrics (Lohr 1990; lezzoni, 1997), estimate incidence of disease 
(McBean, Warren, and Babish 1994), and compare surgical outcomes and 
disease related outcomes and costs (Lubitz et. a/., 1993). Administrative claims 
data are part of the routine clinical reimbursement of health care services, 
allowing for availability of longitudinal data sets, with little cost, and easy 
accessibility. The use of these data to answer health services and outcomes 
related questions are essential, especially in situations where prospectively 
collected data are cost prohibitive or infeasible. 
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In summary, research designed to measure outcomes and best practices 
can be undertaken using inexpensive and efficient retrospective administrative 
data analysis. The cost-effectiveness of different post-stroke rehabilitation 
programs can be examined using administrative data. Consequently, significant 
gains in these previously under examined areas can be achieved in a relatively 
short period of time. 
3.1.1. Medicare Billing Data 
Beginning in the 1980s, researchers began to use administrative data 
from Medicare Parts A and B claims, merged on the individual beneficiary level, 
to study physician payment issues (Mitchell, Bubolz et. al., 1994). However, it 
was not until 1985 that Medicare required providers to utilize a common medical 
procedure coding system that is still in use today. Since that time, researchers 
have used Medicare claims data to construct episodes of care-based analytical 
data files to answer many health services and outcomes related questions 
(Mitchell, Bubolz et. al., 1994). 
Medicare claims data are currently available in a set of related data files 
that are linkable through a non-identifiable unique patient code. This rich source 
of data can be used in the evaluation of medical care as these claims include 
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information on all services provided to Medicare beneficiaries, including: hospital 
events (Part A, including hospitalization diagnoses, procedures, dates, costs 
excluding clinician charges and payments, discharge destination, etc.), 
supplemental insurance provider files (Part B, including clinician and specialty 
charges and payments and their associated diagnostic and procedure codes with 
dates of service), nursing home files (including related dates, charges, payments, 
etc.), home health service files (including related dates, charges, payments, etc.), 
outpatient visit files (including related diagnoses, procedures, dates, charges, 
payments, etc.), and durable medical equipment files (including related dates, 
charges, payments, etc.). A file commonly known as a "denominator" file is also 
included which gives demographic patient information (including age group, race, 
gender, and zip code) as well as month and year of death (if applicable). Files to 
trace data back to providers are also available. With the recent inclusion of 
prescription drug coverage under Medicare Part 0, data files containing 
information regarding the use of prescription drug information are promised to be 
available in the near future but were not available in the current study's data files. 
The Centers for Medicare and Medicaid Services (CMS) require all 
providers to submit bills for payment using diagnosis and procedure codes that 
are standardized. Outpatient clinical visits are coded using Healthcare Common 
Procedure Coding System (HCPCS) which is based on Current Procedural 
Terminology codes (CPT). Hospitalization bills are based on diagnosis codes 
using International Classification of Diseases, 9th Revision, Clinical Modification 
(ICD-9-CM), although hospital bills will often contain multiple diagnosis (ICD-9-
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CM) and procedure (CPT) codes for each episode (or line item). Since private 
insurers tend to follow the lead of CMS, the same coding practices are used for 
billing private insurers in the US as well. The ICD-9-CM coding system is also in 
use by many countries around the world. In fact, many other westernized 
countries have already adopted the next generation of coding, ICD-10-CM, which 
is scheduled to go into use in the United States on October 1, 2013. 
3.1.2. Reasons to Utilize Medicare data in this Research 
The benefits of utilizing billing data for epidemiological, clinical, or health 
services research are many; however, researchers must also be aware of a 
number of constraints and inherent weaknesses in this type of research. The 
positives of these data outweigh the negatives with regard to utilizing 
retrospective billing data to answer health services questions. This is particularly 
true in studies wishing to answer longer term questions that require cost and 
clinical data. This type of research can be very time consuming and costly when 
undertaken as a prospective study. Furthermore, in health services research, 
medical care practices and policies can change rapidly over time, which make it 
difficult to control possible time-related biases even when data is collected 
prospectively. Funding for this type of research has historically been limited in the 
US which makes the utilization of inexpensive, readily available data even more 
valuable to health services researchers wishing to examine healthcare practice 
patterns. The strengths of utilizing these readily available retrospective Medicare 
billing data sets include: 
1. their size, or ability to provide large samples; 
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2. their longitudinal nature, or ability for researchers to follow patients 
over very long periods of time that are most often contiguous; 
3. their availability at little expense; and 
4. their representativeness of the population that covers most of the 
elderly (~ 65 years of age) and the long-term disabled US 
population. 
Some constraints of these data include: their lack of coverage of the 
privately insured US population; lack of representation in those under 65 years of 
age; limitations in the ability of the diagnosis codes to differentiate things such as 
initial event or repeat event, side of the body, clinical severity of disease or 
condition; and whether or not the event is a comorbidity or a complication of the 
condition under study. These data also do not contain other important clinical 
characteristics of care that might influence research results such as disease 
severity. 
Utilizing Medicare data for research purposes can also include a set of 
unalterable challenges. One weakness is the variation of provider coding 
practices and the fact that coding is done for billing and not expressly for 
research purposes. Coding practices also change over time so longitudinal 
research based on these data must be done with care and with the awareness 
that issues might arise due to these changes. Also, the sheer size of Medicare 
data files takes knowledgeable and skilled programmers to properly manage and 
organize prior to analysis. Despite the challenges present when using these data, 
utilizing administrative billing data offers the best opportunity to answer the 
questions in this study. 
3.1.3. Other Sources of Archival Data 
Other sources of archival health data include data sets created via 
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medical record abstraction or via patient derived data (Iezzoni, 1994). Patient 
derived data can be collected directly from patients either by interview or survey 
and may be retrospective or prospective in nature. Collection of these data can 
be time and cost prohibitive. These data are usually limited to clinical information 
and generally do not include related costs of care, which is needed to answer the 
questions posed in this study. 
Some commonly used surveys that are expressly taken for healthcare 
research or disease surveillance include national surveys that are done by 
governmental or private agencies in regular time intervals. Survey data can be 
inexpensive and readily available, however survey data do not usually allow 
researchers to follow particular patients over a long period of time and rarely 
have cost data included with clinical information. They also tend to be limited by 
patient recall and subjectivity. Some examples of survey data sources are: the 
National Survey on Drug Use and Health (NSDUH), the BRFSS, the National 
Health and Nutrition Examination Survey (NHANES), the Medical Expenditure 
Panel Survey (MEPS), the National Health Interview Survey (NHIS), the National 
Survey of Sexual Health and Behavior (NSSHB), and the Annenberg National 
Health Communication Survey (ANHCS). These data sources have different 
associated costs, logistical complications, and feasibility implications (Iezzoni, 
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1994}. More importantly, these main sources of survey data all have specific foci, 
none of which is amenable to addressing the questions of rehabilitation use and 
cost. 
3.2. Estimating Cost of Illness 
Understanding the cost of an illness is important to help inform decision-
making related to resource allocation and policymaking, as well as to support 
cost effectiveness analysis of treatment interventions (Drummond, Sculpher et. 
al., 2005). Governmental planners use disease cost estimates, along with 
incidence and prevalence estimates of diseases to help plan for the availability of 
budgetary dollars that pay for healthcare services, facilities, and staffing. 
There are a wide range of strategies used to estimate disease cost 
depending on available data and on the goals of the study. One method begins 
by estimating total cost of illness based on ascribing unit cost to estimated 
incidence or prevalence rates (Evans, 1990). This method may underestimate 
costs because it will miss any effect that a disease may have on other conditions, 
such as depression or pain (Luengo-Fernandez, Gray & Rothwell, 2009). 
Furthermore, this costing method suffers from lack of evidence gained by use of 
patient-level data. Another common method of estimating cost of illness is to 
aggregate total direct medical costs on patient level population based data after 
an index medical event over a period of time. This is often referred to as "all-
cause" costing or total healthcare cost. The aggregated "all-cause" costing 
approach will likely include health care costs related to any comorbid illnesses 
which are present or arise during the time period, and will therefore tend to 
overestimate costs attributable to the disease under study. 
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This research project uses a third method to estimate cost of ischemic 
stroke, marginal cost estimation, which may be expected to more accurately 
estimate true cost of care (Luengo-Fernandez, Gray & Rothwell, 2009). Marginal 
cost, also known as case-control cost comparison, is calculated by estimating the 
costs of resources used for care after an index event, using population based 
patient-level data, less the cost of a similar patient population who do not have 
the illness, over the same period of time. Arguably, this is one of the more 
precise ways to estimate overall cost-of-illness, especially in the case of stroke 
where most patients are older and have many comorbid conditions which tend to 
increase cost (Luengo-Fernandez, Gray & Rothwell, 2009). 
3.2.1. Quality Metrics of Cost of Illness Studies 
In an article entitled, "Costs of Stroke Using Patient-Level Data: A Critical 
Review of the Literature" by Luengo-Fernandez and colleagues, the authors 
specify that there are two ways to derive estimates of cost of illness, either by 
expert opinion, or analysis based on patient-level data (Luengo-Fernandez, Gray 
& Rothwell, 2009). They based their systematic review search on whether cost 
studies on cerebrovascular disease satisfied four criteria that signify quality 
research. Estimates based on patient-level data are preferred as they can be 
considered evidence based methods. However, all methods utilizing patient-level 
data are not equal as far as the validity, reliability, or generalizability of results. 
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The first quality metric described in the Luengo-Fernandez review article is 
the use of appropriate costing methodologies data (Luengo-Fernandez, Gray & 
Rothwell, 2009), and was based on a modified checklist developed by the British 
Medical Journal (Drummond & Jefferson, 1996). The authors define appropriate 
use of costing methodologies as those that included: whether or not the study 
objectives were clearly stated and justified; if the data collection contains 
descriptions of unit costs and resource use; as well as, if the methods used were 
appropriate; and if the analysis and interpretation of results were reasonable 
(Luengo-Fernandez, Gray & Rothwell, 2009). 
The second quality research criterion described in this manuscript is 
based on if the study sample is representative of the overall population. The third 
criterion is concerned with whether or not the study takes into account the 
premorbid use of resources (Luengo-Fernandez, Gray & Rothwell, 2009). 
Accounting for the comorbidities of patients prior to the indexed illness is 
especially important when studying an elderly population since these patients 
tend to have a great deal of comorbidities and are more likely to consume a large 
amount of healthcare resources in addition to the illness under study. The last 
criterion used by these authors to assess study quality is whether or not the 
researchers report costs while taking into account patient characteristics, 
subtypes, severity, and disease etiology (Luengo-Fernandez, Gray & Rothwell, 
2009). 
During the seventeen year period of the Luengo-Fernandez and coauthors 
review of cost of stroke research studies (from 1990-2007), the authors identified 
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120 studies that meet their inclusion criteria: inclusion of cerebrovascular 
diseases (CVD), published in English, based in westernized countries, resource 
use derived using patient-level data, mean or median costs were reported, and 
study sample of at least twenty patients (Luengo-Fernandez, Gray & Rothwell, 
2009). Of these studies, only 6 compared the costs of cerebrovascular (CV) 
patients with those with no history of CV events. Unfortunately, the authors did 
not indicate the specific references for these studies and did not provide a meta-
table of study information. However, they reported that of the economic studies 
undertaken during the review time period, very few used appropriate cost-
comparison techniques, where attributable or associated cost is estimated. 
Luengo-Fernandez and colleagues concluded that disease costs 
estimates vary considerably based on differences in time periods and follow-up 
time horizons, geographic location, results based on charges versus unit cost, 
and inclusion of productivity loss costs (Luengo-Fernandez, Gray & Rothwell, 
2009). The authors found a 10-fold difference in cost estimates between Eastern 
European studies and studies taking place in either the United Kingdom or the 
US (Luengo-Fernandez, Gray & Rothwell, 2009). However, differences in cost 
estimates within the US were even more disparate. In the 53 studies estimating 
stroke costs in the US, a 20-fold difference was found (cost range $7,309 -
$146,149) (Luengo-Fernandez, Gray & Rothwell, 2009). So while the authors 
concur with many of the costing studies, that CVD poses a significant economic 
burden to societies, what might be the biggest "take-home" message is that the 
large variation in estimates may feed into the perception that these studies are 
not reliable which may hinder healthcare policy decision making. 
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In another recent systematic review entitled, "US Cost Burden of Ischemic 
Stroke: A Systematic Literature Review", Demaerschalk and colleagues 
examined US studies focusing on the cost of ischemic stroke from 1995 to July 
2008 (Demaerschalk, Hwang & Leung, 201 Ob). The authors of this study 
concluded that most US stroke cost studies focus primarily on short-term costs, 
particularly hospitalization. They also noted that no studies were identified where 
the cost of rehabilitation care was estimated (Demaerschalk, Hwang & Leung, 
2010b). This systematic review article concludes by stressing the need for more 
studies that focus on the long-term costs of stroke, particularly rehabilitation 
services and indirect costs. They also note that more recent overall cost studies 
are needed since most studies that they found were analyzed using 1990s data 
(Demaerschalk, Hwang & Leung, 2010b). 
3.2.2. Principles of Costing 
In a publication by Evans entitled, "Principles Involved in Costing", 
suggested that all attempts to calculate cost of illness should be done with care 
and take into account four important principal considerations (Evans, 1990). The 
first principle of costing that Evans gives is the determination of viewpoint taken 
in the analysis. Viewpoints in relation to economic studies can be taken from a 
number of perspectives, including those of the patient, hospital, insurance 
company, government, or society as a whole (Evans, 1990). Evans differentiates 
all analyses of costs to individual entities, such as the patient or the insurer, as 
"financial costs", while costs from the perspective of society as an "economic 
cost" (Evans, 1990). 
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The second principle of costing that Evans stipulates is the differentiation 
between direct and indirect costs. He defines direct medical costs as the "value 
of resources used to prevent, detect, treat and rehabilitate the health impairment 
or its effects"; while indirect costs are defined as "the output lost by patients, their 
relatives, and friends because of the impairment" (Evans, 1990). The inclusion of 
indirect costs in an economic evaluation of illness may be reasonable if the 
viewpoint of the study is from the societal or individual perspective. Otherwise, 
the inclusion of costs such as lost productivity may not be important from the 
perspective of an insurer or a hospital. 
The third, and perhaps most import cost of illness principle, is the value of 
average cost versus marginal cost. Evans notes that "the cost of treating 
additional patients and the savings available because fewer patients require 
treatment cannot, in general, be equated to the average cost of treating existing 
patients". He contends that when one measures average cost, included in these 
costs are "operating costs" or "overhead costs", such as building maintenance or 
administrative staffing, which will occur whether or not a single additional patient 
becomes ill. From the perspective of cost-of-illness based on potential benefits of 
prevention, average costs will always overestimate the cost of adding one 
additional patient or the savings from one less patient because one fewer patient 
will not reduce the need to employ custodial or administrative staff or to maintain 
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the building. This is the primary reason that marginal costs should be used when 
examining most cost of illness questions (Evans, 1990). 
The last principle that Evans contends should be well understood prior to 
undertaking a costing study, is the value of discounting when costs occur at 
different time periods (Evans, 1990). This idea is based on the principle that a 
dollar spent today is more valuable than a dollar spent in the future, because the 
benefits of spending today will be felt much sooner. Similarly, from today's 
perspective, a dollar received today has more value than one received tomorrow. 
For this reason, all costing studies that take place or are interpreted from a 
perspective of multiple years should undergo discounting, where "future costs 
(and benefits) are discounted back to their present values" (Evans, 1990). 
Evans offers insightful suggestions about the interpretation and general 
value of cost-of-illness studies. He clarifies that cost studies alone do not give 
enough evidence to directly guide public policy but provide baseline values 
needed to measure changes due to treatment interventions or healthcare system 
effects over time. Evidence of the effectiveness or efficiency of a particular 
intervention is needed in order to directly guide policy decisions. Incidence-based 
cost-of-illness estimates are valuable. However, to gauge the overall economic 
impact that a potential program or intervention may have one must consider 
outcomes. Other direct benefits of these types of studies include guidance to 
planners of future healthcare needs and provision of data for cost-effectiveness 
analyses. 
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3.3. Accuracy of ICD-9-CM Code Selection 
In complex chronic conditions such as stroke, cost and outcomes research 
are usually performed using large retrospective administrative databases. 
However the utility of using these databases to examine stroke outcomes is 
limited by the reliability of administrative coding to correctly identify stroke 
patients. The current and most commonly used diagnosis coding mechanism in 
the US is the International Classification of Diseases, 9th revision, Clinical 
Modification system (ICD-9-CM) (Rinaldi, Vignatelli et. a/., 2003). 
In 2001, Reker and colleagues examined studies from the 1990's that 
validated the accuracy of stroke ICD-9-CM codes, finding widely disparate 
methods and results (Reker, Hamilton et. a/., 2001). After examining other 
studies, Reker, et. AI., proceeded to undertake their own study of the "best" code 
group to select, using two strategies: 1) maximization of sensitivity (identification 
of patients with new stroke) and 2) maximization of specificity (limiting accidental 
inclusion of non-stroke patients) (Reker, Hamilton et. al., 2001). In many cases 
only the Positive Predictive Value (PPV) is available in these studies as a 
measure of accuracy since many of these studies sample based on a stroke 
cohort, which under-represents non-stroke patients. 
While the list of general ICD-9 codes for cerebrovascular disease shown 
in Table 3-1 (Rinaldi, Vignatelli et. a/., 2003) appear clearly defined, there are 
many sources of variation in hospital-specific coding practices, such as inter-
coder reliability, poor clarity in medical charts, differences in data quality between 
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hospitals or healthcare organizations, or lack of precision of the codes 
themselves (Rinaldi, Vignatelli et. a/., 2003; Wahl, Rodgers et. a/., 2010). 
Table 3-1. ICD-9 Codes for Cerebrovascular Disease 
ICD-9 Code ICD-9 Classification Heading 
430.xx Subarachnoid hemorrhage 
431.xx Intracerebral hemorrhage 
432.xx Other and unspecified intracranial hemorrhage 
433.xx Occlusion and stenosis of precerebral arteries 
434.xx Occlusion of cerebral arteries 
435.xx Transient cerebral ischemia 
436.xx Acute, but ill-defined, cerebrovascular disease 
437.xx Other and ill-defined cerebrovascular disease 
438.xx Late effects of cerebrovascular disease 
Additionally, some investigators will specify samples using only the first 
three digits in the ICD-9-CM codes and some indicate the need to restrict code 
selection to further sub-classification up to the fourth and fifth. Investigators must 
also consider whether or not to include diagnosis of stroke from only the primary 
diagnosis position in the data set or in the primary and collection of secondary 
diagnosis variables. 
Extra caution should be taken in studies intending to estimate stroke 
incidence or prevalence rates since overestimation is likely to occur (Reker, 
Hamilton et. a/., 2001). When using administrative data to estimate incidence and 
prevalence using ICD-9-CM codes, it has been well documented that estimates 
can vary greatly depending on which codes are included (Reker, Hamilton et. a/., 
2001). Different code sets should be used when deciding which ICD-9-CM 
codes are best for estimating disease burden versus if the study objective is to 
47 
garner a patient cohort of individuals who have had a stroke. In the latter case, a 
method of specificity and PPV maximization is preferred. 
Codes used to select stroke population samples should be well defined. 
For example, certain individual codes are reasonable to use if selection of 
specific stroke sub-types are intended, particularly those for intracerebral 
hemorrhage (431.x), or transient ischemic attack (43S.x) (Reker, Hamilton et. a/., 
2001). However, study findings differ as to the accuracy of the use of ICO-9-CM 
code 430.x in correctly identifying patients with subarachnoid hemorrhage 
(Kokotailo & Hill, 2005; Leone, Capponi et. al., 2004; Reker, Hamilton et. al., 
2001; Tirschwell & Longstreth, 2002). If researchers have a large population 
based database available, and intend to sample a cohort of individuals with 
ischemic stroke for analysis of outcomes, the most consistently accurate ICO-9-
eM codes which to use to garner the sample appear to be 434.xx and 436.x 
(Reker, Hamilton et. a/., 2001). When the intention is to use a set of ICO-9-CM 
codes to correctly identify a "high specificity all strokes" cohort, Reker and 
colleagues confirm, in a well-designed large sample study, that codes 431.x, 
434.xx, and 436.x in any diagnosis position result in good accuracy (Reker, 
Hamilton et. a/., 2001). Thus, when planning research using ICD-9-CM codes to 
identify patients with ischemic stroke, where the study question aims to minimize 
inclusion of patients incorrectly diagnosed with stroke, using ICO-9-CM 
diagnoses codes 434.xx and 436.x in the primary variable field for identification is 
best. 
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3.4. Taking into account Comorbidity and Severity of Illness 
The importance of appropriately controlling for factors, such as disease 
severity and the presence of comorbid conditions when analyzing data from 
patients with stroke or other complex chronic conditions is well documented. 
Severity and comorbidity measures are used in a variety of situations from 
clinical trials, to epidemiologic studies, and cost-effectiveness analysis, where it 
is important to be able to control for disease severity in order to properly quantify 
the true difference in outcomes between comparison groups. Without accounting 
for differences in comorbidities and disease severity when analyzing 
retrospective cohort or case-control data, a researcher may not be sure if 
differences found between groups are attributable to the problem under study or 
are simply due to population differences. 
3.4.1. Measuring Comorbidity 
There are many indices of comorbid conditions that have been developed 
and used for analysis of a variety of health related outcomes. An example of 
such an index that was developed to control for comorbid conditions in the 
analysis of hospital data is the Charlson Morbidity Index (CMI). The CMI is an 
excellent model of the value that an index can provide due to its utility of 
controlling for health-related population differences when analyzing 
administrative data repositories. The CMI was originally developed to abstract 
medical diagnoses from inpatient medical records and combine them into a 
single index to be used as an independent covariate in the analysis of hospital 
outcomes and a proxy measure of a patients' 1-year mortality probability 
(Charlson et. al., 1987). 
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Since the development of the CMI, there have been cross-walks from 
diagnoses on medical records, to ICD-9-CM diagnosis codes that are available 
from hospital billing data (Deyo et al. 1992, Elixhauser et al. 1998). The ability of 
the CMI to be translated from its original diagnosis categories and weights, to 
ICD-9-CM diagnosis codes, has made it the single most commonly used 
morbidity index in the analysis of both prospective and retrospective data for 
many different types of disorders and diseases. In contrast, there are no 
established indices of stroke severity for use with administrative data. This 
project utilized similar principles to cross-walked a set of codes to estimate stroke 
severity. This set of codes will be studied in-depth for reliability and validity in 
future research. 
In a Medline search of research conducted since 1997, the CMI was used 
in 573 published research projects to help control for extraneous factors that 
might affect the outcomes or costs being studied. In order to assess differences 
in groups, all other possible independent factors that may affect the outcome 
being studied must be controlled for within the analysis. Severity of illness and 
comorbid conditions are the two main factors, outside of demographic 
descriptors, that are used to account for these independent predictors of health 
related outcomes. 
For example, if it is a researchers' goal to estimate the 1-year attributable 
cost of a post-stroke condition such as the communication disorder aphasia in 
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Medicare patients who have suffered an ischemic stroke using state provided 
Medicare hospital billing data, we would need to add up the total costs for each 
patient who suffered a stroke in the targeted time period and analyze if the 
average annualized health-related cost in the patients who have had aphasia due 
to stroke, differs from those who did not have aphasia. In order to be confident 
that our cost difference is due to aphasia we would need to make sure that our 
two groups, aphasics and non-aphasics, had equal comorbidities as well as 
equal stroke severity. If we are not able to control for comorbid conditions and 
level of stroke severity, we could not be sure that the cost difference was due to 
having aphasia or to one group having poorer health than the other. 
3.4.2. Measuring Disease Severity 
In complex chronic conditions such as stroke, cost and outcomes research 
are usually performed using large retrospective administrative databases. 
However the utility of using these databases to examine longer-term stroke 
outcomes is limited by the lack of an availability of a stroke severity measure. 
This hinders proper evaluation of rehabilitation related outcomes among 
individuals varying significantly in severity due to our inability to control for 
severity of illness. In order to assess differences in groups, the analysis must 
include adjustments for all other independent factors that may affect the outcome 
being studied. 
In studies involving ischemic stroke related outcomes the most commonly 
used severity measures in the United States are the NIHSS or the modified 
Rankin Scale (mRS). These scales are inconsistently collected in hospital 
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medical records and usually require capture in a systematic prospective manner 
in order to be used in clinical trials or other similar studies. Unfortunately even 
within the vast amount of retrospective data derived from administrative 
databases; there is currently not a good measurement of stroke severity that can 
be used as an independent predictor of outcome or as a means for matching 
patients. 
The development of a stroke severity index that can be derived from 
administrative data would allow researchers to answer a vast array of longer-
term stroke outcomes and rehabilitation related questions. We could better detect 
differences in post-acute access to physical, occupational, or speech-language 
therapy programs; answer questions related to predictors of re-stroke; and 
compare costs of treatment programs and outcomes among groups with differing 
stroke severity. All of these questions could provide the evidence needed to 
direct future clinical research questions, resource allocation, and policy decision 
making. 
Since both an individual's severity of illness and the presence of 
comorbidities can potentially influence overall probability of continued morbidity 
or death, analyses for patient outcomes research must adjust for these factors to 
properly account for variation of health status within patient cohorts. A selection 
of codes to use to account for stroke severity in this analysis has been previously 
reported in an applied cost of illness study (Ellis, Simpson et. a/., 2012). Based 
on an examination of evidence presented in previous research a series of codes 
were selected based on their diagnostic relationship with the NIHSS. These 
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codes include: dysarthria (784.5), aphasia (784.3), dysphagia (787.2), 
hemianopia (368.4x), sensory impairment (782.0), neglect (781.8), memory loss 
(780.93), and hemiplegia (342.xx) (Ellis, Simpson et. a/., 2012). These ICD-9-CM 
codes were selected for their ability to map back to the key components of the 
NIHSS which include: 1) Level of Consciousness, 2) Aphasia Visual Impairments 
(hemianopia - partial, complete, bilateral), 3) Facial Palsy, 4) Motor Arm, 5) 
Motor Leg, 6) Limb Ataxia, 7) Sensory impairment, 8) Dysarthria, and 9) 
Neglect. 
Additional diagnoses and procedures with related codes have been used 
as factors related to stroke severity in previous studies: 1) mechanical ventilation 
(CPT codes 94656, 94657; ICO-9 code 96.7x), 2) placement or revision of a 
gastrostomy tube (CPT codes 43750, 43760, 43761, 43832, 43246; ICO-9 code 
43.11), 3) hemiplegia and hemiparesis (ICO-9 code 342.xx), 4) residual 
neurologic deficits (ICD-9 codes 345.40-345.51 and 345.50-345.91 for epilepsy, 
348.1 for anoxic brain damage, 348.3x for encephalopathy, 780.3x for 
convulsions, and 784.3 for aphasia) (Smith et al. 2005, Lee et al. 2010). 
Current research in the areas of rehabilitation service utilization in stroke 
care is limited by the inability to control for stroke severity which will be greatly 
enhanced by a well designed stroke severity measure for use in administrative 
data. The stroke severity index used in the current research, in combination with 
the CMI, will provide the strongest analytical control available for the analysis of 
retrospective billing data when looking for differences in stroke-related outcomes. 
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3.5. Controlling for Selection Bias 
Selection bias is the bias associated with an unbalanced selection of 
individuals under study. Szklo and Nieto remark that selection bias is particularly 
problematic in case-control studies which is the study designed used for aim 2 of 
the current research study. They define selection bias as, " ... a systematic error in 
the ascertainment of the study subjects - cases or controls in case-control 
studies, ... (that) results in a tendency toward distorting the measures expressing 
the association between exposure and outcomes" (Szklo & Nieto, 2007). 
The objective of randomization in studies on health is to obtain groups that 
are balanced, or comparable, in terms of observed and unobserved group 
characteristics. If this balance is not achieved it may not be clear whether a 
difference observed on a certain outcome of interest is due to the "treatment" 
under study or is the result of underlying differences between the groups. Even in 
randomized studies, balance between groups is analyzed for residual bias. 
However, when using large retrospective observational data sets to 
assess health outcomes, randomization prior to data collection is not possible. 
Therefore, other methods, often referred to as "pseudo-randomization methods", 
must be used in order to balance groups. One well developed and largely 
accepted method to accomplish this task is the utilization of propensity score 
techniques. 
Propensity Score (PS), as described by the founders of the method, 
Rosenbaum and Rubin, is "the conditional probability of assignment to a 
particular treatment given a vector of observed covariates" (Rosenbaum & Rubin, 
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1983). The first step in using this technique is estimating the likelihood (i.e. the 
propensity score) that each individual in the sample would have received "the 
treatment" given a set of their personal characteristics. This is done by estimating 
the probability of inclusion in the group (i.e. having a stroke) given a set of 
covariates, such as age, gender, race, history of hypertension, etc., by using a 
logistic regression. Rosenbaum and Rubin stipulate the importance of thinking of 
PS methods as a study design tool that approximates randomization, rather than 
an analysis tool (Rosenbaum & Rubin, 1983; Rosenbaum & Rubin, 1985; Rubin, 
1997). 
Once the propensity scores have been estimated for each individual they can 
be used in the analysis of interest, i.e. "comparing treatment group effects", in 
three different ways: 1) by matching the controls to the cases by similarity in 
propensity score, 2) by using the propensity score to stratify the analyses, 3) by 
using the propensity score as a covariate in the final multivariable model in order 
to control for possible confounding effect. Interestingly, while the third method 
has been used by many researchers, it is not the correct way to employ a 
technique that was developed to approximate randomization, i.e. garner similarly 
balance comparison groups. Controlling for an individuals' likelihood of being in 
the treatment group does not ensure that groups are balanced on observed 
covariates and is considered an "inferior or mistaken" method to use according to 
Donald B. Rubin, a developer of the method (Rubin, 2004). For this reason, only 
the first two methods to employ the use of propensity scores in observational 
studies will be discussed in the following sections. 
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3.5.1. Propensity Score Stratification Methods 
The method of stratification by propensity score has been used since the 
development of the measure. This is particularly due to the simplicity of 
application and the limitation of computing resources in the early years of using 
propensity scoring methods in observational research studies. Once the logistic 
regression has been used to estimate a propensity score for each study subject, 
the most common PS stratification approach takes the range of the propensity 
scores from the minimum value to the maximum value and divides it into five 
equally sized strata and these strata are then used to match similar controls to 
cases (Austin, 2009). Once this stratification variable is developed, it is used as a 
continuous covariate in the multivariable analysis of interest along with the 
original covariates that were used in the logistic regression model development 
of the PS. It has been demonstrated that using this stratification method 
eliminates approximately 90% of the bias due to the measured confounders and 
is a very good way to control for selection bias caused by observed baseline 
characteristics (Rosenbaum & Rubin, 1983). 
3.5.2. Propensity Score Matching Methods 
One must carefully select a well-matched control group, using proven 
techniques, when estimating marginal cost. It is also important to understand why 
marginal cost is a superior method to estimate cost of illness when compared to 
other costing strategies. Recent studies comparing the ability of propensity score 
matching, i.e. matching a case with a control or a number of controls based on 
an algorithmic set distance, have indicated a superior ability of propensity score 
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matching to balance groups in observational studies, over the older stratification 
methodology (Austin, 2009). There are a number of mathematical algorithms with 
which matching can be performed with today's computing power, although the 
most commonly used is "nearest neighbor matching" using a "greedy algorithm". 
Besides deciding which algorithm to use, the researchers must also consider the 
structure, i.e. 1 case to 1 control paired matching, 1 case to many controls 
matching, or optimal full matching which allows all controls to be matched to 
cases but does not ensure an equal number of matched controls to cases (Gu & 
Rosenbaum, 1993). The distance metric used between case and control pairing 
must also be considered. Lastly, one must also consider if the matching of cases 
to controls will be done with or without replacement. 
In an applied example comparing propensity score methods, Austin and 
Mamdani concluded that using a greedy-match algorithm with caliper distance 
set to a maximum width of 0.2 standard deviations of the logit of the estimated 
propensity score and a 1 case to 1 control matching scheme, without 
replacement, resulted in superior overall performance and eliminated systematic 
differences between treatment groups when compared to stratification methods 
or using PS as a controlling covariate (Austin & Mamdani, 2006). In a second 
theoretical simulation study comparing some of these matching practices, the 
authors concluded that a more computationally complex form of optimal 
matching, using total distance between all controls to one case, rather than 
nearest neighbor matching criterion, did not improve the balance between groups 
(Gu & Rosenbaum, 1993). When considering the structure of matching (1 : 1 
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versus 1:m versus complete optimal matching), practical considerations are 
important when examining whether or not to match controls to cases with or 
without replacement. Whether selecting to match with or without replacement of 
controls, one must consider the complexity of statistical techniques needed when 
using "with replacement" since this creates situations where there are many 
within match group dependencies (Austin, 2009). 
3.6. Summary 
There are methodological issues that must be considered in order to 
maximize the potential of the research when utilizing retrospective billing data to 
examine HSR questions. A cost and time efficient way to examine health 
services utilization and cost of illness is to analyze long-term, readily available 
administrative data. Methods to control for population differences, such as 
estimating and controlling for comorbidities and disease severity, are essential to 
ensure that conclusions reached are valid and unbiased. It is important to choose 
procedural and diagnosis codes carefully when constructing cohorts using this 
type of data, otherwise individuals may be erroneously included or excluded 
which may introduce bias. It is also important to control selection bias by utilizing 
techniques such as propensity score matching during analysis of this type of 
data. 
Calculating the cost of stroke is important to help inform policy decision-
making for future resource allocation, as well as to support cost-effectiveness 
studies. Marginal cost is one of the best methods to calculate cost of illness, 
particularly in populations with more comorbidity such as the in elderly. It is 
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essential to have a similar comparison group when estimating marginal cost and 
the best method for which to garner well matched groups in this type of research 
is to use propensity score matching methods. 
Therefore, the purpose of this study is to examine the effect of Medicare 
outpatient rehabilitation caps enacted in the Balanced Budget Act of 1997 on the 
utilization of post-acute stroke rehabilitation services and their associated costs. 
This research project also estimated the total versus marginal cost of ischemic 
stroke in South Carolina in 2004 and the proportion of those costs that were post-
acute rehabilitation services related. These estimates provide an important 
benchmark for which to compare future estimates and may help provide inputs to 
better estimate Medicare funding needs. They also allow healthcare 
professionals, researchers, and policymakers to recognize the difference 
between estimating the total annual cost of healthcare for patients with an acute 
event versus the marginal cost of healthcare due to the acute event. Particularly 
in illnesses that predominately occur in the older Medicare population, the 
difference between measuring cost of illness as total cost of care versus marginal 
will likely be much more extreme than what would be expected in a younger 
population that uses fewer healthcare services each year. 
4. METHODS 
This study was designed to examine the utilization and cost of 
rehabilitation services in Medicare patients with ischemic stroke in the state of 
South Carolina in order to improve our understanding of: 
1) rehabilitation services utilization and cost changes in 1997 versus 2004, 
and 
2) the 2004 marginal cost of stroke, over and above normal costs expected 
in a similar non-stroke population, and the proportion of marginal costs 
attributable to rehabilitation. 
The aims and hypotheses of this study are as follows: 
AIM 1 
To examine the cost and utilization of rehabilitation services (PT, OT, 
SLP), before and after the 1997 Balance Budget Act. 
Hypotheses 
H1: Rehabilitation utilization (measured as proportion TT over cap) among those 
who receive rehab after stroke is greater in 1997 than 2004. 
Ho: TT over cap (provider) 1997 = TT over cap (provider) 2004 
Ha: TT over cap (provider) 1997 ¢ TT over cap (provider) 2004 
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H2: Rehabilitation cost (fJ payments) among those who receive rehab after stroke 
is greater in 1997 than 2004. 
H 0: fJ rehab cost 1997 = fJ rehab cost 2004 
Ha: fJrehab cost 1997 ¢ fJ rehab cost 2004 
Rationale 
It is important to understand the effects of structural changes in 
governmental health care spending regulations (therapy caps) on the process of 
rehabilitation services utilization and outcome of cost. 
AIM2 
To determine the cost of stroke-related healthcare and stroke-related 
rehabilitation care for South Carolina Medicare patients in 2004 and examine 
what proportion of the cost is rehabilitation related. 
Hypotheses 
H1: The 1-year cost of stroke healthcare services (fJ payments) is greater than 
the cost of care (fJ payments) of the matched control Group. 
Ho: fJ cost of care (2004 stroke group) = JJ cost of care (2004 control group) 
Ha: fJ cost of care (2004 stroke group) ¢ fJ cost of care (2004 control group) 
H2: The 1-year cost of rehabilitation services (JJ payments) is greater than the 
cost of rehabilitation care (fJ payments) of the matched control Group. 
Ho: fJ cost of rehabilitation-related care (2004 stroke group) = IJ cost of rehabilitation-related care (2004 
control group) 
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Ha: I.J cost of rehabilitation-related care (2004 stroke group) ¢ I.J cost of rehabilitation-related care (2004 
control group) 
H3: The proportion (n) of the marginal cost of stroke that is rehab-related is 
greater than the proportion (n) of rehab-related care using total cost of 
stroke, in 2004. 
Ho: TT marginal rehab-related cost/marginal cost 2004 = TT total rehab-related cost/total cost 2004 
Ha: TT rehab-related cost/marginal cost 2004 ¢ TT rehab-related cost/total cost 2004 
Study Rationale 
Cost of illness has been historically reported as direct total healthcare cost 
and has never been compared as a marginal cost difference with an equally ill, 
non-stroke, control group. Therefore the outcome of cost of illness has been 
historically misrepresented in a population that tends to have a great amount of 
I 
care costs that are related to comorbidities. The over-estimation caused by 
estimating cost of illness using t6tal cost of care results in an under-estimation of 
the impact and need for stroke rehabilitation. 
The primary endpoints that were used to support the examinations of aims 
1 and 2 of this research are embedded in an applied theoretical view of the 
Donabedian Structure-Process-Outcome model in Figure 4-1 below. 
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Figure 4-1. Primary Study Endpoints Related to Theoretical Framework of Aims 
STRUCTURE PROCESS OUTCOME 
Aiml Proport.'otj· ove r the Ct7P Aim 2 
__ ,.,...... Tota,l Fi'ehab C05t ----+-"" Proportion c4!r::c:hob C05t 
4.1. Study Design 
Aim 1 of this study uses a retrospective cohort design where Medicare 
beneficiaries with index ischemic stroke in 1997 are followed until death or up 
until 1 year after stroke, whichever comes first. The 1997 stroke cohort is 
compared with a similarly selected and followed cohort having an index ischemic 
stroke in 2004. Aim 2 of this study utilizes a retrospective case-control research 
design. SC Medicare data from 2004 are used to select a set of ischemic stroke 
cases. Each stroke case is matched with two non-stroke controls from the same 
year. Cases and controls are followed for c:t year or until death, whichever comes 
first. Matching controls to case is performed using propensity score techniques in 
order to control for potential selection bias. 
A retrospective longitudinal cohort of patients with a primary diagnosis of 
ischemic stroke was extracted from the SC Medicare hospital discharge 
Standard Analytic File (SAF) database that contained data for the years 1996, 
1997, 1998,2003,2004, and 2005. Aim 1 cohort groups are expressed as the 
"early cohort", referring to the group of 1997 ischemic stroke patients, and the 
"late cohort" describing the 2004 ischemic stroke patients. Patients were 
excluded if their index stroke date did not take place in the appropriate index 
year, either 1997 or 2004. Any patients less than 65 years of age at the time of 
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the hospital admission for their index stroke were also excluded. Stroke patients 
with missing race information or with a primary diagnosis of ischemic stroke that 
resulted in hospitalization in the six months prior to index stroke were also 
excluded. Lastly, patients who expired while in the hospital for their index 
ischemic stroke were excluded. 
Ischemic stroke patients were selected from the 2004 Medicare SAFs in a 
similar manner in aim 2 as for aim 1. The same exclusions were used in aim 2 as 
is described in aim 1 except that individuals who died in hospital for their index 
stroke were not excluded in this analysis. 
4.2. Data Sources 
The data used in this study were provided by the SC Office of Research 
Services (ORS) from a state-wide cohort of Medicare participants from SC which 
was made available to the researchers as part of the EXCEED grant (South 
, 
Carolina EXCEED Project funded by AARQ under DUA #16339 EDG#4081) to 
examine health disparities in minority populations. This study has been reviewed 
and approved by the institutional review board for human subjects at the Medical 
University of South Carolina. 
The current research project utilized six years worth of data, spanning a 
ten year time period, of administrative Medicare billing data. SAFs include data 
collected by the Centers for Medicare and Medicaid Services regarding charges 
and payments for health care services provided to Medicare beneficiaries. 
Medicare SAFs include two sets of files used by providers for billing; durable 
medical equipment (DME) and part B provider bills (also known as carrier files), 
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and five facility billing files including; inpatient, outpatient, home health, skilled 
nursing, and hospice (ResDAC, 2011). Since spending in hospice was negligible 
and utilization of rehabilitation in hospice does not generally occur, this file was 
not used in this study. 
Provider billing includes DME claim files that include final action claim data 
submitted to Medicare by durable medical equipment suppliers. Part B provider 
billing files also fall under provider billing. They contain final action claims data 
submitted by non-institutional providers. Examples of part B providers include; 
physicians, physician assistants, social workers, nurse practitioners, independent 
clinical laboratories, ambulance providers, independent physical and 
occupational therapists, and free-standing ambulatory surgical centers (ResDAC, 
2011 ). 
Facility billing includes final action claims data submitted to Medicare from 
inpatient hospital providers and skilled ~ur.sing facilities for reimbursement of 
facility costs. Facility costs can include services provided by clinical providers 
who are employed by the facility. Home health agency (HHA) claims file contains 
data submitted by HHA providers. Facility billing also includes outpatient claims 
files which contain final action claims submitted by institutional outpatient 
providers such as; hospital outpatient departments, rural health clinics, renal 
dialysis facilities, outpatient rehabilitation facilities, comprehensive outpatient 
rehabilitation facilities, and community mental health center (ResDAC, 2011). 
This type of data has been widely used by researchers to study outcomes, 
epidemiology, and health services rates of utilization among elderly and 
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permanently disabled patients in the US. SC Medicare data from hospital, home 
health, outpatient, skilled nursing, durable medical equipment, and Part B 
provider files were merged together and linked using encrypted beneficiary 
identification numbers. Costs for each patient were aggregated over the study 
time period. 
4.3. Measurement of Variables 
Appendix A provides an overview of the variables supplied in the original 
Medicare data, as well as derived variables that were used in this study. Some 
important variables that were derived for this research, include indicator variables 
of "early" (1997 index stroke) or "late" (2004 index stroke) stroke cohort (aim 1), 
case versus control group indicator (aim 2), and indicator of being over or under 
the outpatient rehabilitation services cap enacted in the BBA of 1997 (aim 1). 
To classify stroke severity, a proxy index of severity for administrative data 
was created using the same criteria thatis .described in previously published 
research (Ellis, Simpson et. al., 2012). Stroke severity was defined as mild if 
patient had no major stroke-related diagnoses (aphasia, dysarthria, dysphagia, 
sensory impairment, hemianopia, neglect, memory loss or hemiplegia) during 
index hospitalization, moderate if at least one stroke-related diagnosis was coded 
(excluding hemiplegia), and severe if hemiplegia or two or more stroke-related 
diagnoses were coded. 
4.4. Data Set Construction: Aim 1 
Beneficiaries' data were linked from different claims files via encrypted 
beneficiary identification numbers at the individual level and followed 
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longitudinally in two groups. The first cohort included patients who had a primary 
diagnosis of acute ischemic stroke requiring hospitalization in 1997 and the 
second cohort of patients included those diagnosed with a primary ischemic 
stroke in 2004 that required hospitalization. Each cohort was followed for the 
remaining time period of available data. The six months prior to stroke for each 
cohort was used to construct the Charlson comorbidity Index up until and 
including index stroke for each patient and were also used to exclude individuals 
with previous ischemic strokes. This ensures that the index stroke is not a recent 
re-stroke and provided a clearer cohort of incident ischemic stroke sufferers with 
a well-defined comorbidity measurement. 
The patient population of interest in this study includes patients 
hospitalized with newly diagnosed acute ischemic stroke in either the year 1997 
or 2004. Patients were selected based on the presence of a primary diagnosis of 
, 
". 
AIS via the most consistently accurate and highly specific ICO-9-CM codes of 
434.xx or 436.x in the hospital impatient claims file (Reker, Hamilton et. a/., 
2001). Patients were excluded from the cohort if they met the following exclusion 
criteria: not enrolled in Medicare in 1996 or 2003, less than 65 years of age, 
indication of previous stroke, not having at least one physician claim in the year 
following stroke unless discharged dead during index hospitalization, or if race 
data is missing. 
The two groups were then be used to compare early (1997) versus late 
(2004) rehabilitation services utilization and cost of physical therapy (PT), 
occupational therapy (OT), and speech or swallowing therapy (SLP). Billing 
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codes were used to identify indicators of rehabilitation use (Appendix B), stroke 
severity, and comorbid conditions. 
ICD-9-CM diagnosis, Healthcare Common procedure coding system 
(HCPCS), and CPT codes were used to identify indicators of rehabilitation 
services use. The following table (Table 4-1) discussed by Zorowitz and 
colleagues, outlines codes that have be used in a past study to define general 
indicators of rehabilitation therapy services use (Zorowitz, Chen et. al., 2009) and 
were used as an initial starting point to help designate rehabilitation use. 
Table 4-1. Zorowitz et. AI. Rehabilitation Code Selections 
Settings Code Code Description 
Type 
Hospital Inpatient ICO-9- V57xx Care involving use of rehab. 
CM 462 procedures 
DRG Rehabilitation 
Hospital outpatient CPT 92506,92507, Evaluation or treatment of speech, 
and primary care 92508 language, voice, communication 
and/or auditory processing 
97001, 97002, Physical therapy evaluation 
97003, 91004, Occupation therapy evaluation 
97010-97039- Application of a modality to one or 
more areas including, but not limited 
to thermal, acoustic, light mechanical 
or electric energy 
97110-97546 Therapeutic procedures one or more 
97703,S7750 areas 
97780, 97781, Tests of measures of physical 
97799 performance 
Other physical medicine/rehabilitation 
services/procedures 
HCPCS G0129 Occupational therapy requiring the 
skills of a qualified occupational 
therapist, furnished as a component of 
a partial hospitalization treatment 
program, per day 
ICO-9- V57xx Care involving use of rehab. 
CM procedures 
Skilled Nursing ICO-9- V57xx Care involving use of rehab. 
Facilities CM procedures 
RUG First three digits: Low/medium/high rehabilitation 
FHA, FHB, RHC, 
RLA, RLB, RMA, 
RMB, RMC 




Home Health Agency HCPCS G0151-G0153 Physical, occupational, speech and 
language in home health setting (each 
15 minutes) 
S8990 Physical or manipulative therapy 
performed for maintenance rather 
than restoration 
S9128, S9129, Speech, occupational, physical 
S9131 therapy at home iPer diem) 
ICO-9- V57xx Care involving use of rehab. 
CM Qrocedures 
This project examined outpatient billing for PT, OT, and SLP services due 
to the potential effects of SBA of 1997 caps specifically on these services. The 
following is a list of CPT codes commonly used by these service groups (Table 4-
2). To distinguish between the service type, Medicare requires these billing 
codes be entered with the modifier "GN" for services delivered under an 
outpatient speech-language pathology plan of care; "GO" for services delivered 
under an outpatient occupational therapy plan of care; or, "GP" for services 
, ,. 
delivered under an outpatient physical therapy plan of care. These modifiers 
were found in 2004 date but did not exist in years before the SSA of 1997 was 
enacted, and was therefore not available in 1997. Outpatient rehabilitation 
--
modifier codes were used to help designate line items in 2004 data but were 
found to be little used. Therefore, rehabilitation codes were also used to define 
line item bills as rehabilitation-related even if they did not have modifier codes 
attached. A list of all rehabilitation codes used to define rehabilitation line items is 
included in Appendix B. 
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Table 4-2. Outpatient PT, OT, and SLP Billing (CPT or HCPCS) Codes 
Clinical Service Codes Description 
SLP 92506 Evaluation of speech, language, voice, 
communication, and/or auditory processing 
92507 Treatment of speech, language, voice, 
communication, and/or auditory processing disorder; 
Individual 
92508 Treatment of speech, language, voice, 
communication, and/or auditory processing disorder; 
group, 2 or more individuals 
92526 Treatment of Swallowing dysfunction and/or oral 
function for feeding 
92610 Evaluation of oral and pharyngeal swallowing function 
92626 Evaluation of auditory rehabilitation status; first hour 
92627 Evaluation of auditory rehabilitation status; each 
additional 15 minutes (List separately) 
PT 97001 Physical TheraQY Evaluation 
97002 Physical TheraQY Re-evaluation 
97110 Therapeutic procedure, one or more areas, each 15 
minutes; therapeutic exercises to develop strength 
and endurance, range of motion and flexibility 
97112 Neuromascular reeducation of movement, balance, 
coordination, kinesthetic sense, posture, and/or 
proprioception for sitting and or standing activities 
97116 Gait Training (includes stair climbingl 
97124 Massage, including effleurage, petrissage and/or 
tapotement (stroking, compression and percussion). 
97140 Manual Therapy Techniques (eg. 
mobilization/manipulation, manual lymphatic drainage, 
manual traction), one or more regions, each 15 
minutes 
97150 Therapeutic procedure(s), group (2 or more 
. individuals). 
OT 97003 Occupational Therapy Evaluation 
97004 Occupational Therapy Re-evaluation 
97140 Manual therapy 
97535 Self-care management training 
G0129 Occupational therapy requiring the skills of a qualified 
occupational therapist, furnished as a component of a 
partial hospitalization treatment program, per day 
G0152 Services performed by a qualified occupational 
therapist in the home health or hospice setting, each 
15 minutes 
G0160 Services performed by a qualified occupational 
therapist, in the home health setting, in the 
establishment or delivery of a safe and effective 
theragy maintenance progJam, each 15 minutes 
S9129 Occupational therapy, in the home, per diem 
G0158 Services performed by a qualified occupational 
therapist assistant in the home health or hospice 
setting, each 15 minutes 
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Once line item rehab utilization had been identified for each individual, 
they were combined to estimate rehabilitation services utilization and cost. Total 
rehabilitation costs were summarized using means and medians and were later 
used to examine their relative proportion to marginal versus total stroke costs. 
4.5. Data Set Construction: Aim 2 
The data set constructed for aim 2 utilized the 2004 index stroke cohort 
from aim 1 as stroke cases without excluding patients who died in the hospital 
during index stroke. A large pool of non-stroke Medicare beneficiaries from the 
same year was used from which to draw the control population. Propensity score 
matching was performed to match two controls to each case. Total medical care 
costs were then aggregated for all controls in the same manner as was done for 
the stroke cases. 
4.6. Statistical Analysis Methods: Aim 1 
, 
Means and standard deviations were calculated to describe continuous 
data for each stroke cohort in aim ·1. Frequencies and percents were calculated 
to describe categorical data. To test for differences in stroke rates, demographic 
and outcome variables between the two stroke groups, chi-square statistics were 
used to test for differences in proportions non-parametric. While Wilcoxon/Mann-
Whitney U statistics were used to test for differences in medians (or ranks). 
Graphing was used as needed to test assumptions as well as to display results. 
Univariate statistical comparisons between groups provide a good initial 
indication of potential significant differences in individual variables. They do not, 
however, adjust for potential confounding covariates commonly influential in non-
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randomized studies and thus must be examined further by using multi-variable 
analysis methods when group differences are found. 
Frequencies and percents were calculated to describe rehabilitation 
services utilization in each of the stroke groups ("early" versus "late"). To test for 
differences in whether or not the proportion of patients over the outpatient 
rehabilitation cap was different between the early and late groups, chi-square 
statistics were calculated. When differences between groups were found, logistic 
regression was used to control for covariates that differed between the groups 
and that were potentially related to the outcome. Covariates included in initial 
models were: age, gender, race, Charlson morbidity score, and number of days 
alive in the year after index stroke. Covariates not found to significantly contribute 
to each model were removed one at a time and the models were then re-fit to the 
data. Final models and covariates are discussed in the results chapter. 
I 
Generalized linear modeling techniques were used to test the hypotheses 
that the total and outpatient provider costs of rehabilitation-related care were 
different between early and late groups. To correct for the non-normal distribution 
of Medicare costs, gamma distributed generalized linear models using a 
logarithmic transformation (Montez-Rath, Christiansen et. al., 2006) were 
analyzed using the PROC GENMOD module in the SAS statistical software 
(version 9.2; SAS Institute, Inc., Cary, NC). The use of a gamma distributed 
generalized linear model with a log transformed link function has been shown to 
be a good method to estimate healthcare cost distributions that are generally 
right-skewed, especially when the log transformed dependent variables do not 
72 
have heavy tails or excessive heteroscedasticity such as was found to be true in 
these data (Manning, Basu & Mullahy, 2005). 
Multicollinearity between covariates was assessed using Pearson 
correlation coefficients. No collinearity was found in these data (all p-values > 
0.25). Clinically relevant variables were used to determine which covariates were 
initially included in the models to control for population differences. Covariate 
adjustment was used to control for differences in cost that may be attributed to 
other factors. Covariates that were tested for potential confounding in model 
estimates of rehabilitation payments included age, gender, race, Charlson 
morbidity score, and number of days alive in the year after index stroke. Final 
models and covariates are discussed in the results chapter. 
Manual backwards selection regression methods were used to decide 
which covariates remained in the final models using smallest Akaike Information 
I 
Criterion (AIC), Bayesian Information Criterion (BIC) values, and covariate p-
values to judge model fit. Variables with p-values greater than 0.20 were 
removed from the models if the AIC and BIC values became smaller than in the 
previous model containing the covariate. All analyses were performed using SAS 
statistical software (version 9.2; SAS Institute, Inc., Cary, NC), and statistical 
significance was determined at the 0.05 level. 
4.7. Statistical Analysis Methods: Aim 2 
The marginal cost of stroke-related healthcare and stroke-related 
rehabilitation care was defined as the cost of caring for patients with stroke after 
index stroke hospital admission that is over and above the cost of general 
73 
medical care in the non-stroke control group over the same time period. Total 
Medicare payments and total rehabilitation services payments were calculated 
using means and unadjusted differences between groups were tested using non-
parametric Wilcoxon Scores (same as Mann-Whitney U Scores). The marginal 
cost of stroke-related rehabilitation was calculated by subtracting the average 
total rehabilitation services payments for the controls, from the average total 
rehabilitation services payments for the stroke cases. Generalized linear models 
controlling for covariate differences were not used for this analysis because 
models would not converge and fit properly due to the large number of patients 
with no rehabilitation payments. However, because adjusted estimate results for 
total Medicare payments were so similar to their unadjusted results, the inability 
to utilize adjusted models in this case is not a major concern. 
Generalized linear modeling techniques were used to estimate average 
, 
annualized total Medicare payments for stroke cases and controls and to test for 
differences between the stroke case and control groups. The 1-year marginal 
cost of stroke-related healthcare was calculated by subtracting the estimated 
total Medicare payments for the controls from the estimated total Medicare 
payments for the stroke cases. 
To correct for the non-normal distribution of Medicare costs, gamma 
distributed generalized linear models using a logarithmic transformation (Montez-
Rath, Christiansen et. a/., 2006) were analyzed using the PROC GENMOD 
module in the SAS statistical software (version 9.2; SAS Institute, Inc., Cary, 
NC). The use of a gamma distributed generalized linear model with a log 
74 
transformed link function has been shown to be a good method to estimate 
healthcare cost distributions that are generally right-skewed, especially when the 
log transformed dependent variables do not have heavy tails or excessive 
heteroscedasticity such as was found to be true in these data (Manning, Basu & 
Mullahy, 2005). 
Multicollinearity between covariates was assessed using Pearson 
correlation coefficients. No collinearity was found in these data (all p-values > 
0.25). Clinically relevant variables were used to determine which covariates were 
initially included in the models to control for population differences. Covariate 
adjustment was used to control for differences in cost that may be attributed to 
other factors. Covariates that were tested for potential confounding in model 
estimates of rehabilitation payments included age, gender, race, Charlson 
morbidity score, and number of days alive in the year after index stroke. Final 
I 
models and covariates are discussed in--the results chapter. 
Manual backwards selection regression methods were used to decide 
which covariates remained in the final models using smallest Akaike Information 
Criterion (AI C), Bayesian Information Criterion (BIC) values, and covariate p-
values to judge model fit. Variables with p-values greater than 0.20 were 
removed from the models if the AIC and BIC values became smaller than in the 
previous model containing the covariate. All analyses were periormed using SAS 
statistical software (version 9.2; SAS Institute, Inc., Cary, NC), and statistical 
significance was determined at the 0.05 level. 
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Propensity score (PS) methods were employed to match cases to 
controls. The first step in this process was to perform logistic regression analysis 
to estimate the propensity of being "allocated to the stroke group". A propensity 
score for each individual was calculated and appended onto the analysis data 
set. Known components related to the risks of having a stroke were included as 
covariates in the logistic regression model (Brookhart, Schneeweiss et. a/., 
2006). Covariates used in the PS model included age, gender, race, Charlson 
comorbidity score, and the following stroke risk factors (as monitored in billing 
records from the six months prior to index study start date): diabetes, heart 
failure, heart attack, atrial fibrillation, and hypertension as well as five interaction 
terms of gender by each risk factor. Final model selection was based on 
hypothesis testing of balance between groups of all the covariates included in the 
propensity score logistic regression models, model with largest r-square value, 
, 
and satisfied reduction of the absolute stC\ndardized differences in means 
between the matched and unmatched data for all covariates «0.25). 
Propensity score methods using a greedy-match algorithm with caliper 
distance set to a width of 0.1 standard deviations of the logit of the estimated 
propensity score and a 1 case to 2 control matching scheme, without 
replacement, was used to match cases with controls in the final analytical data 
set. Simulation studies have shown this method to result in superior overall 
performance that eliminates systematic differences between treatment groups 
(Austin & Mamdani, 2006; Austin, 2009). 
5. RESULTS 
5.1. Aim 1 Results 
5.1.1. Study Cohort Groups Identification and Descriptive 
Characteristics 
1997 Stroke Group 
4,192 patients initially eligible for the "early cohort", who were hospitalized 
for all stroke and ischemic events in 1997, were identified for this aim in a 1997 
stroke cohort file provided by the SC ORS. Of these patients, 113 (2.7%) had 
their index stroke in 1996 and were excluded from this analysis. Of the remaining 
4,079 patients, 539 (12.9%) were also excluded as they were under the 65 year 
age required for study inclusion; 30 (0.70/0) patients had unknown race; 393 
(9.4%) had a primary hospital diagnosis other than the ischemic inclusion codes 
434.xx or 436.xx; 172 (4.1 %) patients had claims in the prior 6 months indicating 
a prior ischemic stroke diagnosis; and an additional 278 (6.6%) patients had 
expired while in hospital for the index stroke and were therefore excluded 
because they were never eligible to receive post-acute outpatient rehabilitation 
services. This left a patient sample of 2,667 in the final 1997 ischemic stroke 
cohort. The process of exclusion is depicted in Figure 5-1. 
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Igure 5 1 I h . St ke Cohorts Identification - sc ernlc ro 
Original 1997 Stroke Cohort Original 2004 Stroke Cohort 
demographic data set demographic data set 
(Containing all stroke (Containing all stroke 
types and TIAs) types and TIAs) 
4192 Patients 4065 Patients 
." N = 4.192 .,,. N = 4.065 
Excluded 113 with Year of Excluded 81 with Year of 
Stroke 1996 Stroke 2003 
N = 4,079 N = 3,984 
" " 
Excluded 539 with age < 65 Excl uded 575 with age < 65 
N = 3.540 N = 3.409 
" ." 
Excluded 30 with unknown Excluded 22 with unknown 
race race 
N = 3,510 N = 3,387 
." ." 
Excl uded 393 with no Excluded 231 with no 
primary hospital diagnosis of primary hospital diagnosis of 
Ischemic Stroke Ischemic Stroke 
(ICD-9-CM codes 434.xx or 436.xx) (ICD-9-CM codes 434.xx or 436.xx) 
N = 3,117 I N = 3,156 .. 
." ." 
Excluded 172 with known Excl uded 152 with known 
primary diagnosis Ischemic primary diagnosis Ischemic 
Stroke in previous 6 months Stroke in previous 6 months 
(lCD-9-CM codes 434.xx or 436.xx) (ICD-9-CM codes 434.xx or 436.xx) 
.., 
" N = 2.945 " N = 3.004 
Excluded 278 Expired in 
Hospital 
Excluded 28 with previous Final 2004 Stroke Group 
index stroke in 1997 f---+ (AIM 2) 
N = 2,976 
.,,. .,,. N = 2,976 
Final 1997 Stroke Cohort Excluded 297 Expired in 
(AIM 1) Hospital 
N = 2,667 
" 
Final 2004 Stroke Cohort 
(AIM 1) 
N = 2,679 
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2004 Stroke Group 
The 2004 "late cohort" consisted of 4,065 SC Medicare patients who were 
hospitalized for stroke and ischemic events in 2004 in a 2004 stroke cohort file 
provided by the SC ORS. Of these patients, 81 (2.0%) had their index stroke in 
2003 and were excluded from this analysis. Of the remaining 3,984 patients, also 
excluded were 575 (14.10/0) who were under the 65 year age required for study 
inclusion, 22 (0.50/0) patients with unknown race, 231 (5.7%) who had a primary 
hospital diagnosis other than ischemic inclusion codes 434.xx or 436.xx, 152 
(3.70/0) patients with claims in the prior 6 months indicating prior ischemic stroke 
diagnosis, 28 (0.7%) with a previous index stroke in 1997 and who were already 
included in the 1997 cohort, and an additional 297 (7.3%) patients who expired 
while in the hospital for index stroke and were never eligible to receive post-acute 
outpatient rehabilitation services. This left a final patient sample of 2,679 in the 
, 
final 2004 ischemic stroke cohort. The exclusion categories are provided in 
Figure 5-1. 
Group Comparisons 
The 1997 and 2004 stroke cohorts did not differ significantly with respect 
to gender, proportion that died in the year post stroke, the average number of 
days alive in the year after stroke, or average Charlson morbidity score (Table 5-
1). However, the 2004 cohort had a statistically significant higher average age 
(77.9 versus 76.8 years, p-value<0.0001), by just over a year, than the 1997 
cohort (Table 5-1). This statistically significant finding may not be of clinical 
significance, but rather be a mathematical phenomenon commonly seen in large 
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samples where small differences may be statistically significant, but not clinically 
important. The later cohort had a slightly higher proportion of Caucasians than 
the earlier group (71.8% versus 68.8%, p-value=0.02). Interestingly, the 2004 
stroke cohort had a smaller average index hospital length of stay than the 1997 
group, by less than one day (6.8 versus 7.6 days, p-value<0.0001), which may 
reflect the general trend toward shorter hospital stays over time for many 
illnesses observed nationwide in the past 15 years (Bueno, Ross et. al., 2010; 
Clarke & Rosen, 2001; Kominski & Witsberger, 1993). 
The 2004 cohort also comprised of a higher proportion of individuals who 
received rehabilitation services after the acute index hospitalization and who had 
a higher average number of rehabilitation bills in the year following their index 
stroke. These rehabilitation related outcomes are not baseline measures rather 
they are directly related to the primary outcomes of this study but were included 
in Table 5-1 for description only. It is irrfportant to note that use of post-acute 
rehabilitation increased from 20.5% in 1997 to 48.6% in 2004 in SC Medicare 
beneficiaries who had an ischemic stroke (Table 5-1). This increase in utilization 
of rehabilitation services of 28.1 % (p-value <0.0001), is illustrated in Figure 5-2. 
Also important to note is the increase in the average number of rehabilitation bills 
from 1.4 in 1997 to 4.5 per patient in 2004 (p-value <0.0001) (Table 5-1). Not 
only did the rehabilitation bills increase but the standard deviation in the number 
of rehabilitation bills increased almost three fold (Table 5-1). This indicates a 
larger variation in the amount of care provided and may reflect high utilization of 
health care services by a small proportion of individuals. 
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Died yr post-strokeA 
Days Alive year post-stroke t 
Charlson Morbidity Score t 
Length of Stay (days) t 
Receiving RehabilitationA 
# of Rehab. Bills t 
























2004 Stroke Group 
(n=2,679) p-value* 
77.9 (±6.9) <0.0001 
1032 (38.5) 0.22 
1925 (71.8) 0.02 
673 (25.1) 0.74 
307.2 (±112.1) 0.62 
3.1 (±1.6) 0.11 
6.8 (±6.0) <0.0001 
1303 (48.6) <0.0001 
4.5 (±13.3) <0.0001 
*p-values were calculated using non-parametric Wilcoxon Scores for continuous measures, Chi-square or Fisher's Exact 
for categorical measures (as appropriate). 
5.1.2. Characteristics of Stroke Patients Receiving Rehabilitation 
Services 
Of the 2,667 ischemic stroke pati(tnts in the 1997 group, 546 had at least 
one post-acute index hospitalization bill with a rehabilitation services procedure 
or diagnosis code included. Thirteen hundred and three of the 2,679 patients in 
the 2004 cohort had one or more post-acute rehabilitation bills. These sub-
groups are the main focus of the hypotheses in aim 1, patients using 
rehabilitation services in the year after their index stroke (Table 5-2). Within the 
cohorts of patients receiving rehabilitation services, there are a number of 
demographic variables and study characteristics that are unequal between the 
groups. The 2004 group had a higher average age, a lower proportion of males, 
and a greater number of days alive in the year after stroke. The groups did not 
81 
differ in race, morbidity, proportion that died in the year after stroke, or in the 
length of index hospital stay (Table 5-2). 
Table 5-2. Demographic and Characteristics of Ischemic Stroke Patients Using 
Rehabilitation Services 
Overall 1997 Cohort 2004 Cohort 
(n=1,849) (n=546) (n=1,303) p-value* 
Age (approximate)t 77.1 (±6.7) 75.8 (±6.6) 77.6 (±6.6) <0.0001 
Male" 806 (39.6) 241 (44.1) 482 (37.0) 0.004 
CaucasianJ\ 1298 (70.2) 381 (69.8) 917 (70.4) 0.80 
Died year post-strokeJ\ 347 (18.8) 90 (16.5) 257 (19.7) 0.13 
Days Alive yr post-stroke t 328.5 (±87.6) 331.7 (±86.4) 327.2 (±88.1) <0.0001 
Charlson Morbidity Score t 3.1 (±1.6) 3.2 (±1.5) 3.1 (±1.6) 0.06 
Length of Stay (days) t 7.2 (±6.0) 7.1 (±5.5) 7.2 (±6.2) 0.51 
Over the Cap (all outpatient bills)J\ 1016 (55.0) 174 (31.9) 842 (64.6) <0.0001 
Over the Cap (outpatient provider)" 127 (6.9) 52 (9.5) 75 (5.8) <0.004 
t Mean (SD) 
... N (%) 
*p-values were calculated using non-parametric Wilcoxon Scores for continuous measures, Chi-square or Fisher's Exact 
for categorical measures (as appropriate). 
r ,. 
In unadjusted models assessing the proportion of individuals with 
rehabilitation charges above the total outpatient rehabilitation cap, 32.7% 
(p<0.0001) more individuals were above the cap in 2004 (capped level of $3,180) 
than in 1997 (cap level $3,000) (Table 5-2). However, when examining only the 
Medicare Part B provider bills the opposite was found to be true. In the 1997 
cohort, 9.5% of stroke patients had Part B expenditures above the total cap while 
only 5.8% exceeded the cap in 2004 (p-value <0.004) (Table 5-2). This may be 
reflecting a shift in how outpatient rehabilitation services were being billed. 
These differences are shown in Figure 5-2. 
Fi ure 5-2. Rehabilitation Services Utilization 





.1997 . 2004 
9.5% 
5.8% 
Overthe Cap (Rehab. 
Outpatient Provider Bills) 
5.1.3. Rehabilitation Services Utilization 
64.6% 
31.9% 
Over the Cap (All Rehab. 
Bills) 
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The findings from the univariate analysis for rehabilitation utilization results 
did not change when examined using rT!ultivariable logistic regression models 
". 
when controlling for clinically relevant covariates: age, gender, days alive in the 
year post-stroke, and level of stroke. In 2004, South Carolina ischemic stroke 
patients over the age of 65 who were-hospitalized for their stroke, and who 
received some type of rehabilitation services after their index hospitalization, had 
3.7 (p-value <0.00001) times the odds of exceeding the total $3,180 outpatient 
rehabilitation services cap than those in the 1997 Medicare cohort (based on the 
level set the following year at $3,000). If only the outpatient Medicare Part B 
provider bills were used to assess the odds of exceeding the cap, the opposite 
result was found. The odds of the 2004 cohort exceeding the cap, using only the 
provider bills, are 0.60 (p-value <0.007) the odds of being above the cap in 1997. 
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When examining rehabilitation services utilization after ischemic stroke 
from the provider cost perspective, average payments were higher or remained 
similar between the two cohorts (Table 5-3). In order to account for inflation, 
1997 Medicare payments were adjusted to 2004 dollars by using the Consumer 
Price Index medical care services estimates provided by the Bureau of Labor 
Statistics (Consumer Price Index, 2012). 
Total rehabilitation costs per patient were greater in 2004 than in 1997, 
even after adjusting the data for inflation. Estimated 1-year adjusted total 
rehabilitation payments were $9,606 in 2004 compared with $5,691 (inflation 
adjusted) in 1997 (p-value <0.001) (Table 5-3). While utilization of any 
rehabilitation services after ischemic Stroke increased by 32.7% from 1997 to 
2004, the average cost increased by just under $4,000. Although not statistically 
significant, the estimated cost of rehabilitation services for Medicare Part B 
provider billing appears to decrease slightly over this time period (p=0.12) (Table 
5-3). Among patients receiving rehabilitation services, total 1-year Medicare 
payments fell from 1997 to 2004 by $3,987 (p<0.001) (Table 5-3). 
Table 5-3. Rehabilitation Services Medicare Payments for Stroke Patients Receiving Rehabilitation t 
Overall 
(n=1849) 
Total Medicare Payments 33,882 (23921) 
Estimated Total Medicare Payments# 
Total Rehab. Payments 7,127 (10193) 
Estimated Total Rehab. PaymentsA 
aT 1,029 (3089) 
PT 2,478 (4854) 
SLP 569 (2366) 
PT & SLP 3,047 (5985) 
General (unspecified) 3,050 (6265) 
Provider Rehab. Payments 847 (4023) 


















































$ 1997 payment amounts adjusted to 2004 US$ using Consumer Price Index series CUUROOOOSAM2 annual medical care services 1.34 adjustment (Bureau of Labor Statistics) 
*p-values for univariate comparisons were calculated using non-parametric Wilcoxon Scores for continuous measures, 
# p-value for estimated total Medicare payments were calculated using multivariable Log linked Gamma Distributed Generalized Linear Model, controlling for race and number of days 
alive in year post stoke. 
II p-value for estimated total rehabilitation payments were calculated using multivariable Log linked Gamma Distributed Generalized Linear Model, controlling for race, age 
approximation, number of days alive in year post stoke, and stroke severity. 
$ p-value for estimated outpatient rehabilitation payments were calculated using multivariable Log linked Gamma Distributed Generalized Linear Model, controlling for gender, race, 
and number of days alive in year post stoke. 
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5.2Aim 2 Results 
5.2.1 Characteristics of the 2004 Stroke Cohort and the Matched 
Control Group 
The 2004 Ischemic stroke cohort used in aim 2 of this study is very similar 
but not identical to 2004 group used in aim 1. Figure 5-1 shows the flow diagram 
of how the stroke groups were selected. The aim 2 ischemic stroke cases were 
selected identically to the approach used in aim1 until the final exclusionary step 
where subjects who died in-hospital after their index stroke were either excluded, 
as was completed in aim 1, or not excluded, as was completed in the present 
aim. 
The primary purpose of aim 1 was to evaluate post-acute stroke 
rehabilitation, which requires all subjects to be alive after acute treatment in order 
, 
to have the opportunity to receive rehabnit~tion services. In aim 2, the goal is to 
estimate the 1-year marginal cost ··of stroke for all ischemic stroke patients over 
age 65, including those that die during initial hospitalization. For this reason, the 
stroke group in aim 2 of this study differed slightly in sample size and population 
composition to that of aim 1. Two thousand nine hundred and seventy six 
ischemic stroke cases were matched to a cohort of 5,952 controls on age, 
gender, race, Charlson morbidity score, and the following stroke risk factors (as 
monitored in billing records from the six months prior to index study start date): 
diabetes, heart failure, heart attack, atrial fibrillation, and hypertension using a PS 
matching procedure. Potential control patients were excluded if billing data for 
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their indexed year, or prior six months, contained ischemic stroke diagnosis 
codes. In addition to the nine covariates listed above, five interaction terms of 
gender by each risk factor were also included in the propensity model in order to 
help achieve an improved gender balance. Controls were selected from a group 
of 17,924 potential Medicare beneficiaries that met the same inclusion criteria 
used to select the ischemic stroke cohort. A, two controls to one stroke case, 
matching scheme was performed based on propensity score similarity via a 
computerized matching algorithm as discussed in the methods section. 
Table 5-4. Demographics and Characteristics of 2004 Ischemic Stroke Patients 
and Matched Controls 
Overall 
(n=8928) 
Age (Approximate) t 78.2 (±6.B) 
MaieA 3510 (39.3) 
CaucasianA 6374 (71.4) 
Charlson Morbidity Score t 2.1 (±1.7) 
Receiving RehabilitationA 2438 (27.3) 
Died Year Post-Index DateA 1975 (22.1) 
Days Alive Yr Post-Index Datet 309.1 (±115.2) 













2004 Stroke 2004 Controls 
(n=2976) (n=5952) p-value* 
78.1 (±6.9) 78.3 (±6.8) 0.14 
1149 (38.6) 2361 (39.7) 0.33 
2148 (72.2) 4226 (71.0) 0.24 
7.1 (±1.7) 2.0 (±1.6) 0.10 ,. 
1303 (43.8) 1135(19.1) <0.0001 
967 (32.5) 1008 (16.9) <0.0001 
279.2 (±136.1) 324.0 (±99.8) <0.0001 
991 (33.3) 2027 (34.1) 0.48 
851 (28.6) 1755 (29.5) 0.38 
280 (9.4) 487 (8.2) 0.06 
832 (28.0) 1591 (26.7) 0.22 
2476 (83.2) 5036 (84.6) 0.09 
*p-values were calculated using non-parametric Wilcoxon Scores for continuous measures, Chi-square or Fisher's Exact 
for categorical measures (as appropriate). 
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5.2.2 Propensity Score Matching Results 
Each of the propensity score matched covariates resulted in statistically 
equal groups on these known potentially biasing factors. Unadjusted outcomes 
such as, average number of days alive in the year after index study start date 
(stroke date for the stroke cohort and randomly selected 2004 medical bill date 
for the control group), proportion receiving any rehabilitation services in the year 
after index date, and proportion who died in the year after index study date, were 
all higher in the stroke cohort versus the control group (p-values <0.0001) (Table 
5-4). 
A plot of the absolute standardized differences in means, as seen in 
Figure 5-3, offers a good representation of whether selection bias of known 
factors has been reduced by matching on propensity score (Stuart, 2010). 
Balance (i.e. reduction in standardized mean differences between stroke cases 
I 
and selected controls) for each covariafe that was used in the logistic regression 
model of propensity, is improved when differences are reduced after matching to 
no greater than 0.25 (Rubin, 2001). Figure 5-3 illustrates that the standardized 
differences in means for each of the fourteen covariates included in the 
propensity model is reduced to less than the 0.25 recommended level after 
matching. This resulted in a reduction in selection bias on all known covariates 
after matching which is the intended goal of propensity score matching 
(Rosenbaum & Rubin, 1983). An added benefit of this matching approach was a 
reduction in the selection bias of other unmeasured factors that are correlated 
with the known covariates used in this matching algorithm. This gives confidence 
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that we have a well matched observational study design that is unlikely to have 
much selection bias. 
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5.2.3 Marginal Cost of Stroke in SC 
The estimated average healthcare cost in the first year after ischemic 
stroke in 2004 was $27,330 (Table 5-6). Average estimated healthcare costs in 
the control group was significantly lower at $18,276 (p-value <0.0001) (Table 5-
6). Therefore, the marginal cost of stroke, defined as the cost of healthcare for 
an average individual who has had and ischemic stroke, over and above the 
normal average cost seen in a similar group who have not suffered a stroke, 
was the difference between these group estimates, or $9,054 (Table 5-6). 
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Table 5-6. Rehabilitation Services Medicare Costs for 2004 Stroke Cohort and 







Total Medicare Payments 21,220 (28267) 27,329 (23913) 18,165 (29745) <0.0001 
Estimated Total Medicare Payments# 27,330 18,276 <0.0001 
1-year Marginal Cost of Stroke-Related Healthcare $9,054 
Total Rehabilitation Services Payments 1,968 (5887) 3,735 (8245) 1,084 (3958) <0.0001 
1-year Marginal Cost of Stroke-Related Rehabilitation $2,651 
t All payments are in 2004 US$ and are reported as mean (SO); payments have been rounded to the nearest dollar. 
*p-values for univariate comparisons were calculated using non-parametric Wilcoxon Scores for continuous measures, 
# p-values for estimated payments were calculated using multivariable Log linked Gamma Distributed Generalized Linear 
Model. 
The average cost of rehabilitation after stroke in 2004 was $3,735, 
significantly more than average rehabilitation services cost for the controls (p-
value <0.0001) (Table 5-6). The difference between the rehabilitation costs in 
these two groups is the 1-year marginal cost of stroke-related rehabilitation care, 
or $2,651 (Table 5-6.). Both the average total healthcare cost differences and 
rehabilitation cost differences are illustrated in Figure 5-4. 
Fi ure 5-4. 1-Year Cost of Ischemic Stroke in SC 
i-Year Cost of Ischemic Stroke 
(2004) 





Overall Heathcare Rehabilitation Care 
The proportion of the marginal cost of stroke that is rehabilitation-related 
was greater than the proportion of rehabilitation-related care using total cost of 
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This research examines rehabilitation services utilization and healthcare 
cost during the year after acute ischemic stroke in South Carolina. More 
specifically, how the caps on outpatient rehabilitation services required by the US 
Balance Budget Act of 1997 impacted utilization and cost by comparing stroke 
cohorts from before and after the legislation was enacted. The one-year 
attributable healthcare costs of ischemic stroke was also examined by calculating 
the marginal estimated healthcare Medicare payment difference between a 2004 
ischemic stroke cohort and a propensity matched 2004 non-stroke control group. 
This latter question is innovative becau~e the marginal cost of illness has never 
been published for an elderly stroke cohort, and marginal cost is the preferred 
method of cost of illness estimation for many purposes; specifically, it is an 
essential input for cost-effectiveness studies for this disease group. 
One of the objectives of this research was to estimate the proportion of 
healthcare dollars spend on rehabilitation services in the year after ischemic 
stroke. Estimates of rehabilitation expenditures are extremely varied and are 
often underestimated due to the fact that they are estimated as a proportion of 
annual total healthcare expenditure, rather than as a proportion of the marginal 
cost attributable to a specific illness. Because the type of data available to 
answer these questions is retrospective observational billing data, special 
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methods must be used to properly minimize selection bias. Also, because costs 
are being estimated, statistical methods should be used that can effectively 
model skewed distributions that are commonly associated with healthcare costs. 
There are four primary findings from this research. First, the BBA of 1997 
outpatient rehabilitation services caps did constrain the costs of Medicare Part B 
provider services when rehabilitation bills were examined. However, the second 
finding was that all other rehabilitation services billing contained within outpatient 
facility charges continued to rise significantly over the study time period. Third, 
findings related to the second study aim clearly demonstrated that the total cost 
of healthcare after ischemic stroke significantly overestimates the cost of stroke 
as an illness because the marginal cost of stroke in this elderly population is 
attenuated by healthcare costs related to comorbidities. Fourth, estimates of the 
proportion of healthcare dollars spent on rehabilitation services using total annual 
, 
healthcare expenditures, rather than margi.nal costs, underestimates the 
proportion of rehabilitation services used after stroke. The proportion of dollars 
spent on stroke-related rehabilitation services is better estimated by calculating 
marginal stroke-related healthcare costs rather than total healthcare costs. This 
is because the amount of expenditures incurred for other non-stroke related 
healthcare needs in this older population is quite large. These findings and 
related issues are discussed below, followed by a discussion of the limitations of 
this study, future directions, and opportunities in this line of research. 
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6.1 Aim 1 Discussion 
The first aim of this study examined the cost and utilization of rehabilitation 
services before and after the 1997 BBA. The proportion of stroke patients 
exceeding the cap in 2004 after the 1997 BBA was enacted, was lower (5.8 %) 
than those in 1997 (9.5%) had there been a cap at that time (p-value=0.004). 
These numbers, however, do not reflect the t~ spending on rehabilitation 
services outside of hospital settings. They represent only the portion of 
rehabilitation services that are billed to Medicare via Part B outpatient provider 
files. 
Rehabilitation services can also be billed via home health facility, 
outpatient facility, and skilled nursing facility billing. When we examined the 
proportion of individuals exceeding the cap among both the outpatient provider 
and facility files, there was a greater proportion of stroke patients in 2004 (64.60/0) 
, 
than in 1997 (31.90/0) who exceeded the" cap (p-value <0.0001). The same 
relationship was found when examining the 1-year cost of rehabilitation services 
after acute ischemic stroke among patients who are eligible for these services. 
The estimated average 1-year Medicare payments for rehabilitation services, 
when examining only the Part B outpatient provider bills, did not differ between 
the cohorts (p=0.12), and, in fact, decreased slightly from $1 ,052 in 1997 (after 
adjustment for inflation) to $833 in 2004. However, when examining rehabilitation 
costs using all available outpatient Medicare bills, the average estimated 
payments greatly increased (p-value <0.0001) from 1997 when it was $5,691 to 
$9,606 in 2004 after inflation adjustment. 
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These results suggest that billing practices may have changed in 
response to the outpatient rehabilitation services caps enacted by the BBA of 
1997. Rehabilitation services billing may have shifted from Part B provider bills to 
being more frequently included in facility charges. In fact, the average number of 
bills containing an indication of services performed by aPT, OT, or SLP 
increased greatly over this time period from 1.4 in 1997 to 4.5 per patient in 2004 
(p-value <0.0001 ). 
Not only did the number of rehabilitation bills increase but we observed a 
greater variation in billing as indicated by the standard deviation in the number of 
rehabilitation bills increasing almost three fold. This indicates a larger variation in 
the amount of care provided and may reflect a high utilization of health care 
services by a small proportion of individuals which has been noted in numerous 
reports (Andersen & Newman, 2005; McKinsey and Company, December 2008) 
to be a major contributing factor of the exp.onential growth of US healthcare 
expenditures. It should also be considered a warning that potential disparities in 
access to care could be increasing. 
In addition, the number of stroke patients receiving some amount of 
rehabilitation services after acute ischemic stroke has greatly increased during 
this time period. The proportion of patients using rehabilitation services after 
their stroke increased from 20.5% in 1997 to 48.6% in 2004. This increase in 
utilization of rehabilitation services of 28.1 % (p-value <0.0001), reflects an 
important indication that practice is moving toward compliance with 
recommendations that all stroke survivors receive at least one evaluation visit 
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with aPT, OT, and SLP clinician, and that the unit cost or appropriate utilization 
of rehabilitation services may not be the best legislative focus for cost 
containment. 
No matter what special rules are enacted, healthcare administrators will 
find ways to legally bill Medicare for needed provider services. The focus of 
healthcare cost containment may be better served by reducing the large amount 
of services used by a small portion of the population. The increase in variation of 
the amount of units of rehabilitation services used in the year following ischemic 
stroke indicate that just over 20/0 of Medicare beneficiaries consume more than 
30 rehabilitation services billing units in the year after their 2004 stroke, while this 
proportion of high-use behavior in 1997 resulted in the top 2% consuming only 10 
or more rehabilitation units. The cap on outpatient rehabilitation per person 
annual spending enacted under the BBA of 1997 has also contributed untold time 
and related expenditure on legislative, privpte sector, and public research efforts 
to lobby, debate, and study the issue with little or no supporting evidence that the 
cap is fair or satisfies the goal of cost containment. 
From 1998 through 2000, Olshin, Ciolek, and Hwang report that Medicare 
Part B expenditures for therapy services dropped by 10.3% (Olshin, Ciolek & 
Hwang, 2002). The findings in this study are not directly comparable to what we 
found as a decrease of 14.7% in Part B expenditures from 1997 (adjusted) to 
2004. However, because our time frame was longer than the Olshin, Ciolek and 
Hwang report it is reasonable that the decrease found in our study is greater but 
still in the same direction as this government sponsored research (Olshin, Ciolek 
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& Hwang, 2002). When we adjusted our estimates for gender, race, and the 
number of days alive that year, the difference was no longer statistically 
significant. The Olshin, Ciolek and Hwang group report on all Medicare 
beneficiaries while ours include only those diagnosed with ischemic stroke. Some 
limitations of the Olshin et. al. report is that the authors do not test for a 
statistically significant difference and do not address rehabilitation services that 
are billed under other facility based bills, such as home health or nursing home. 
Another reason for the difference in findings between the current research and 
the Olshin report may be because the government report is based on a national 
sample. 
Indeed, according to US congressional committee members' response to 
the analysis performed by Olshin, Ciolek and Hwang, the Computer Sciences 
Corporation (CSC) results were considered insufficient for informing health 
, 
policy, written in a report from the US government accountability office (GAO) in 
2005 (Grassley, Baucus et. al., 2005). In the GAO report, "Little progress made in 
" 
targeting outpatient payments to beneficiaries needs", the congressional GAO 
authors stated that "the [CSC] contracted analysis of claims data does not show 
any particular conditions or diseases as more likely than others to be associated 
with payments exceeding the therapy caps" (Grassley, Baucus et. al., 2005). 
They go on to suggest that even for conditions such as stroke, claims data 
analysis shows that the length of treatment varies widely (Grassley, Baucus et. 
al., 2005). This is one of the reasons why the current in-depth study, focused 
specifically on stroke patients, may contribute substantially to informing health 
policy. 
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In the most recent analysis by Ciolek and Hwang, the authors remark that 
the initial problems with reduced access to outpatient rehabilitation services seen 
in the early years of the caps appears to no longer be notable once the 
exceptions process was put in place (Ciolek & Hwang, 2008). Our conclusions 
are similar to this report in that it appears that once the healthcare system had 
time to adjust to the legislation it was able to provide services in different 
locations. Thus, access issues do not appear to be a problem in the current 
study, consistent with Ciolek and Hwang. Use of rehabilitation services by larger 
proportions of the Medicare population continue to increase. 
In a study published by the CDC based on 2005 BRFSS survey data, 
30.7% of stroke survivors received outpatient rehabilitation (CDC, 2007). This 
estimate is much lower than found in the c~rrent study, where 48.6% of SC 
Medicare patients who survive hospitalization after ischemic stroke receive 
rehabilitation services. In additional to other limitations of BRFSS data related to 
survey sampling, the lower estimate in the BRFSS survey may be due to the fact 
that those data are based on subjective recall and only represent non-
institutionalized individuals which excludes anyone in nursing home or inpatient 
rehabilitation facilities at the time of the survey. Also, rehabilitation rates may 
vary from the national sample to the current South Carolina based study data. 
Nevertheless, these estimates continue to indicate that there may still be a 
concern that clinical practice guidelines recommend outpatient rehabilitation for 
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the majority of stroke survivors (Adams, Brott et. a/., 1994; Adams, del Zappa et. 
a/., 2007). It is quite unlikely that the more than half of stroke patients who do not 
receive rehabilitation services do not need, at a minimum, rehabilitation 
assessment. We suspect that these patients simply are unable to negotiate the 
entry points into the rehabilitation system. This may be a serious problem for 
patients with low health literacy, without family support in negotiations, and with 
cognitive impairments that make them poor advocates for themselves. 
6.2Aim 2 Discussion 
The second aim of this study examined the 1-year difference in healthcare 
costs between a group of SC Medicare beneficiaries who had suffered an 
ischemic stroke in 2004 and a propensity score matched control group of 2004 
non-stroke SC Medicare beneficiaries. In 2004, the estimated marginal cost of 
stroke-related healthcare in the year after ischemic stroke in SC was $9,054. 
, 
This amount reflects the difference betwe~n the annualized healthcare cost of 
the stroke group of $27,330 less the healthcare costs of the propensity score 
matched non-stroke control group of $18,276 (p-value <0.0001). Similarly, the 
2004 marginal cost of stroke-related rehabilitation services in the year after 
ischemic stroke was $2,651, resulting from a statistically significant difference 
between the average annualized total rehabilitation services cost for the stroke 
group of $3,735 and the control group of $1 ,064 (p-value <0.0001). Both the 
average total healthcare cost differences and rehabilitation cost differences are 
illustrated in Figure 5-4. 
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While these amounts are substantial and both clinically and statistically 
significant, they are lower than is commonly quoted as the annual cost of care 
after stroke. A 1996 publication by Taylor, Davis and colleagues is the most 
commonly cited cost of stroke paper with 559 publications referencing this 
research (accessed May 2012) . The Taylor study continues to be referenced 
annually in the stroke cost section by the most well-known review publication on 
stroke statistics, "Heart Disease and Stroke Statistics-2011 update: A report 
from the American Heart Association" (Lloyd-Jones, Adams et. al., 2009; Lloyd-
Jones, Adams et. al., 2010; Roger, Go et. al., 2011b; Rosamond, Flegal et. al., 
2007; Rosamond, Flegal et. al., 2008), even though this research is based on 
1990 data and uses antiquated methodology. This is likely true because there 
have been no more recent, population-based studies on the cost of stroke. 
The authors of the Taylor study estimated the 1990 annual direct cost of 
, 
ischemic stroke in the 65-74 year age groLJP to be $17,823 ($35,197 in 2004 
dollars) versus the annual healthcare expenditures for their control group of 
$2,825 ($5,579 in 2004 dollars) (Taylor, Davis et. al., 1996). This study reports 
the annual direct marginal cost of ischemic stroke of $14,998 in 1990 dollars 
($29,618 in 2004 inflated dollars) which is much higher than we found in the 
current research. Differences between the current research and that undertaken 
by Taylor and colleagues in their 1997 publication are related to differences in 
the methods used to estimate these dollar amounts and in changes in healthcare 
practice patterns. 
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A significant trend toward shorter hospital average length of stay has 
been frequently reported in the literature. In this case, the Taylor study reports 
that 70% of the first year of medical costs can be account for by the initial 
hospitalization; however, the article does not report the average length of stay. In 
the current study, initial hospital costs only account for 35% of the first year of 
total healthcare costs. This reflects a change in practice patterns of shorter 
average hospital stays from the 1980s to today (Bueno, Ross et. a/., 2010; 
Clarke & Rosen, 2001; Kominski & Witsberger, 1993). Shorter length of stay 
would result in lower first year healthcare cost estimates in later studies, however 
these reductions may be counteracted by inflation adjustment over time. 
The Taylor et. al. study includes a 5% Medicare sample of the 1990 US 
population, while the current study uses all SC Medicare patients with ischemic 
strokes in 2004. Taylor et. al. also used an average cost to charge ratio for all 
admissions to estimate stroke costs whil~ the current research used actual 
Medicare payments. Estimates based on cost to charge ratios for all admissions 
can skew costs because stroke costs may not follow general hospital cost to 
charge trends. While the current research uses actual payments made by 
Medicare to the provider and does not make any assumptions in the costing 
methods. Also, the Taylor research used a 1 in 1,000 randomly selected, non-
matched control group from the general US Medicare population. This practice 
would likely under estimate the control groups' healthcare expenditures because 
the average Medicare population is more likely to be healthier than a control 
group matched on an equally at-risk population. This, outdated matching 
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approach, would result in inflated marginal cost estimates. This study addresses 
the potential selection bias caused by unmatched controls by using propensity 
score matching to match the stroke cases to controls, which results in a more 
conservative and reasonable marginal cost estimate. An added benefit of the 
matching approach used in the current study was a reduction in the selection 
bias of other unmeasured factors that are correlated with the known covariates 
used in this matching algorithm. This gives confidence that the observational 
study is well matched and is unlikely to contain much selection bias. 
In a seminal study by Samsa and colleagues, the 2-year cost and survival 
after cerebral infarction was estimated based on 1991 data (Samsa, Bian et. a/., 
1999). This publication, which has been cited 130 times (accessed May 2012), 
reports the first year cost of first ever ischemic stroke in the over 65 Medicare 
population as $29,444 (in 1991 dollars) (Samsa, Bian et. a/., 1999). The Samsa 
estimate is very similar to the current stady's 1-year cost estimate of $27,330, but 
the current study is based on 2004 Medicare payments while theirs is calculated 
using 1991 data. The Samsa study estimated total average cost rather than 
marginal cost. In 1991 the average length of hospital stay after acute stroke was 
considerably longer than it was in 2004, resulting in inflated estimates when 
compared to current practice. Their estimates also used cost-to-charge ratio 
adjusted Medicare charges for all facility bills, rather than payments, which has 
an unknown effect on the costs incurred by Medicare. So while this is a good 
study on the cost of ischemic stroke using a comparable population the estimates 
provided by Samsa et. al. are no longer applicable to the current healthcare 
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system and do not take into account the cost of the non-stroke care that surviving 
stroke patients are likely to incur even if they did not have a stroke. 
The Samsa study exemplifies the inflated estimation of costs that result 
from reporting total healthcare cost instead of marginal cost of care, particularly 
in the group examined in this study. Older individuals tend to have significant 
healthcare costs outside of the particular major illness being studied, which make 
it essential to take into account other costs when estimating the costs attributable 
to a single disease. 
In a more recent study by Brown et. aI., epidemiological modeling was 
performed to estimate the cost burden of ischemic stroke from 2005 through 
2050 (Brown, Boden-Albala et. al., 2006). The authors suggest that they use 
marginal cost in their projections for hospital and nursing home expenditures; 
however, they reference the Samsa paper for these amounts which are not 
based on marginal cost. Also, the reseafct"1 published by Brown and colleagues is 
not population based, but is mode"led by using previously published results from 
studies covering many different time periods, using different methodology. 
Furthermore, it is not clear if and how the authors adjust for inflationary trends 
which add to questions raised on the quality of their research estimates. 
The use of total annualized healthcare expenditures to estimate the cost 
of a certain illness may also contribute to underestimation of certain portions of 
the cost attributable to specific healthcare services. For instance, within the 2004 
stroke cohort, the proportion of total healthcare costs spent on rehabilitation 
services is 13.7% , as illustrated in Figure 6-1. However, if one uses the 2004 
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marginal costs of stroke and rehabilitation services due to stroke, the proportion 
of costs attributable to rehabilitation services is 29.3%. Since our goal is to 
specify costs of care that are specifically due to ischemic stroke, the marginal 
cost is the better method of estimation of these costs because they exclude the 
expected cost of non-stroke related healthcare that patients would have used if 
they did not have a stroke. Thus, as illustrated in Figure 6-1, the estimation of the 
proportion of dollars spent on rehabilitation care after stroke is undervalued by 
two-fold unless marginal cost estimation is used. This error can be found in the 
commonly referenced estimates by Taylor and colleagues, based on 1991 data, 
which state that 70% of first-year post-stroke costs are accounted for by inpatient 
hospital costs (Taylor, Davis et. a/., 1996). Not only is this proportional estimate 
based on total annualized healthcare costs, but it is also from a time period 
where hospital length of stay was considerably longer and therefore more 
expensive than what is true in healthcar~ t~day. 
Figure 6-1. Proportion of the 1-Year Cost of Ischemic Stroke Spent on 
Rehabilitation Services 
i-Year Cost of Ischemic Stroke 
(2004) 
• Total Cost II Marginal Cost 
29.3% 
13.7% 
Proportion Spent on Rehabilitation 
Ciolek and Hwang reported in 2006 that outpatient therapy services 
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payments for rehabilitation totaled $4.07 billion in 2006 (Ciolek & Hwang, 2008). 
Of these PT accounted for 75%, OT for, 18.4% and SLP 6.6% (Ciolek & Hwang, ,. 
2008). They observed that the relative proportion of services by therapy type was 
consistent with prior years. These estimates were based on data from 4,419,907 
individuals for a mean expenditure per person $921 (Ciolek & Hwang, 2008) 
which corresponds closely to the findings for the per person annual expenditure 
of our 2004 control group of $1,084. The slightly higher number found in the 2004 
control group could be due to the exclusion of individuals under 65 years of age 
which were not excluded in the Ciolek and Hwang report. The Ciolek and Hwang 
reported 2004 expenditures, provided in Figure 2 page 8 of the 2006 report 
indicates a mean expenditure of $1 ,000 per individual (Ciolek & Hwang, 2008). 
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The close correlation of the findings between Ciolek and Hwang and the current 
study indicate that the findings in this study have high external validity. 
Based on stroke estimates from the current study, 1-year total healthcare 
cost to SC Medicare in 2004 of beneficiaries having ischemic stroke was 
$81,334,080 and total annualized 2004 SC Medicare rehabilitation costs due to 
ischemic stroke was $11,115,360 (Table 6-1). However, if quoting marginal 
rather than total cost, the annualized stroke-related healthcare costs to SC 
Medicare in 2004 were $26,944,704 (Table 6-1). This reflects a potential $54.4 
million over-estimation of Medicare expenditures that were not due to ischemic 
stroke. Similarly, the marginal cost of stroke-related rehabilitation care in 2004 in 
SC Medicare patients having ischemic stroke was $7,889,376, resulting in a $3.2 
million over-estimation if total rehabilitation costs are quoted (Table 6-1). 
Table 6-1. Cost of Ischemic Stroke to Medicare in SC and the US 
2004 SC 2012 2012 2004 SC 2012 
Stroke Projected Projected Rehab- Projected 
Costs SC Stroke US Stroke Related SC 




Total Cost $81.3 M $109.5 M $7,319.3 M $11.1 M $15.0 M 
Marginal Cost $26.9 M $36.3 M $2,424.8 M $7.9 M $10.6 M 














* Cost estimates are based on costs and incidence rates using the 2004 Stroke Group from this study and are rounded to 
the nearest tenth of a million SUS dollar 
# The number of 2004 Medicare beneficiaries used to estimate SC costs to Medicare was taken from Kaiser Family 
Foundation State Health Facts website (www.statehealthfacts.org, accessed on 05/25/2012) 
t 2012 SUS dollars cost projections were calculated using 2004 estimates inflated by Consumer Price Index series 
CUUROOOOSAM2 annual medical care services adjustment (Bureau of Labor Statistics) 
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When these 2004 SC Medicare stroke cost estimates are inflated using 
the Consumer Price Index for healthcare services to make 2012 dollar 
projections, 2012 SC Medicare annualized stroke-related healthcare and 
rehabilitation care costs would be over-estimated by $73.2 million and $4.34 
million, respectively (Consumer Price Index, 2012) (Table 6-1). When SC stroke 
rates and costs estimated in this study are used to predict Medicare costs for all 
US ischemic stroke patients, 2012 total stroke costs are predicted to be $7.32 
billion compared with 2012 marginal stroke-related healthcare costs of only $2.42 
billion, resulting in an over-estimation of stroke-related expenditures of $4.89 
billion (Table 6-1). Similarly, utilizing total cost instead of marginal cost figures to 
predict stroke-related rehabilitation care costs of 2012 Medicare beneficiaries 
would result in an over-estimate of $290 million (Table 6-1 ) .. 
There are many policy issues related to the use of inflated estimates for 
, 
stroke. When it is generally felt that commonly quoted figures related to incidence 
rates, prevalence rate"s, proportional estimates of certain services and cost 
estimates are inflated, the public, including those in the research community, 
begin to become immune to the numbers. The research community may believe 
that it is okay to inflate cost estimates in order to help support arguments for 
increased funding. However this practice may negatively affect funding for other 
important research since there are limited dollars to support health-related 
research efforts. Furthermore, when advocacy and governmental groups quote 
these inflated estimates they lose credibility with the public and their ability to 
make good policy decisions are diminished. 
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For this reason it should be imperative for the research community to 
report reasonable findings so that funding agencies can properly designate 
research dollars in a balanced manner, commensurate with the degree to which 
the healthcare issue affects society. A good example of this is the lower funding 
for post-acute stroke rehabilitation research compared with acute stroke 
treatment due to the antiquated belief that hospital costs account for the largest 
percentage of stroke-related costs. 
6.3 Limitations 
There are several limitations in the analysis of SC Medicare claims data. 
There is an inherent limitation of using administrative claims to ascertain 
diagnoses and identify resource use and costs with complete accuracy, because 
these data are not purposely collected for clinical research but are collected for 
the distinct purpose of making healthcare payments. It is possible that signs or 
symptoms related to stroke may not have Qeen captured in the claims, and that 
ischemic stroke patients not diagnosed with 434.xx and 436.xx ICD-9-CM codes 
under the primary diagnosis category would be missed by this analysis. Similarly, 
the measurement of rehabilitation and general resource use in these data 
depends on the design and implementation of the Medicare fee-far-service plan 
and its scope of coverage which may change over time. Medicare reimbursement 
rules and healthcare practice patterns that change over time may also make 
these 2004 based results less generalizable to current times. The use of SC 
estimates from this research may not be representative of stroke costs and 
rehabilitation utilization in other states and in the US since healthcare practice 
patterns and costs vary geographically. In addition, the interpretation of 
rehabilitation resource use and the assignment of associated costs are 
challenging. 
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Due to the lack of availability of clinical information in these claims data, 
the classification of rehabilitation was based on the inclusion of specific 
rehabilitation related codes in the ten diagnosis code and four procedure coding 
columns provided in the data files. Provider billing systems will often allow for a 
much longer list of these codes when interpreting medical records into billing 
data in the clinical setting. So it is reasonable to assume that some diagnoses or 
procedures related to stroke and rehabilitation would not be included in the 
Medicare data. 
Clinical outcomes are not available in billing data and costs can be 
significantly influenced by clinical factors such as stroke severity. In response to 
this concern, we developed and used a~ qn-validated coding-related stroke 
severity measure designed to mimic the NIH stroke scale in our multivariable 
analyses. Also, as becomes clear in aim 2 of this study, when using billing codes 
to identify rehabilitation resource use, the reason for such use is directly related 
to the index stroke. Stroke patients may also receive rehabilitation for other 
comorbidities which would then be erroneously counted as stroke-related unless 
being accounted for in a marginal use or cost analysis that uses a similarly 
distributed control group. 
An additional challenge was presented by the way Medicare bills are 
aggregated in the data. Facility based bills, such as those listed in outpatient, 
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home health, and skilled nursing files, do not provide line-item specific 
information. For example, a single bill from a skilled nursing facility can include 
one payment for all charges incurred over a 3~-day period since Medicare's 
prospective payment system generally only reimburses these as a single 
allowable amount. So while this bill may have procedure and diagnosis codes 
that include rehabilitation services, the actual cost of that service is not 
differentiated within the payment amount. This differs with Part B provider bills 
which are coded on a line-item basis, so each bill will directly reflect the payment 
for the service that is specified in the procedure or diagnosis codes. 
In addition, we intended to examine differences in payments for provider types 
(PT, OT, SLP) but had to abandon this analysis because ICD-9, CPT, and 
HCSPCS coding use in the data was too inconsistent to differentiate clearly 
between provider types (Appendix B). For example, the most commonly used 
CPT/HCSPCS code in the data, "9711 d - Therapy Procedure", is used by both 
PT and OT professionals. The co"ding differentiation between provider types 
improved slightly between 1997 and 2004 but remained too general to allow for 
clear delineation between providers. In theory, modifier codes that designated 
the outpatient rehabilitation services practitioner, ("GO" for OT, "GP" for PT, and 
"GN" for SLP) were added by Medicare after the BBA 1997 and are required to 
be used for all outpatient rehabilitation services billing. However, fewer than 100/0 
of bills containing rehabilitation codes actually included modifier designations in 
the better coded 2004 Stroke cohort (Appendix B). Thus, the use of these 
modifier codes is not well enough implemented to support the identification of the 
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type of professional rehabilitation service provider. For that reason we primarily 
examined payments for rehabilitation using total rehabilitation services costs 
rather than provider specific costs. 
Because the goal of the research conducted in aim 1 was to characterize 
the utilization and cost of rehabilitation in patients who might be affected by the 
caps implemented by the BBA of 1997, rehabilitation cost estimates are for 
ischemic stroke patients who survive their acute stroke hospitalization and who 
are identified as receiving any rehabilitation services outside of their initial 
hospitalization. For this reason, patients who died during the acute hospitalization 
or those not identified as receiving rehabilitation services in the year after stroke, 
were excluded. Had these patients been included in the cost analyses, the 
estimated Medicare costs may have differed. 
Lastly, this study evaluated the burden of caring for stroke patients from the 
perspective of the Medicare system. Ad~iti,onal costs such as premiums, 
deductibles, co-insurance, self-paid items, prescription drugs, and indirect stroke-
related expenses were not included in the cost estimates. 
6.4 Future Directions and Opportunities 
The first research aim of this study compares rehabilitation utilization and 
cost before and after the BBA of 1997 enacted caps on outpatient rehabilitation 
services. It provided strong evidence that the caps impacted the cost of 
rehabilitation services that are billed via Medicare Part B provider services, but 
that rehabilitation costs continue to rise when billed in facility settings. 
Furthermore, the current research shows that while the use of rehabilitation 
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services after hospitalization for ischemic stroke continue to increase, contrary to 
current practice guidelines, greater than 50% of eligible Medicare patients do not 
receive rehabilitation services after their stroke. It will be important to examine 
the population who do not receive rehabilitation services for disparities in access 
to care. It will also be important for future research to examine what types of 
stroke impairment are most likely to result in clinician referral for post-stroke 
rehabilitation care. 
The second aim of this study estimated the marginal cost of ischemic 
stroke in SC in the 2004 Medicare population over age 65. While healthcare 
costs for stroke patients were found to be significantly greater than in the 
matched controls, the marginal cost difference between the two was just under 
$10,000. This amount may be surprising in its relative smallness when compared 
to common estimates quoted in past research, but is largely due to the fact that 
the estimate is based on marginal cost aifference and not on total healthcare 
dollars spent. Furthermore, the current studies stroke-related healthcare cost 
estimate is based on a comparison with the annual healthcare costs of an equally 
at-risk matched control group. 
In order to generalize these findings, a similar study based on a national 
sample should be performed and also be undertaken using more recent data. An 
additional analysis should also be performed to update national and global 
lifetime cost of stroke estimates that would be valid to replace the 25 year old 
data estimates published by Taylor and colleagues (Taylor, Davis et. al., 1996). 
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Another future direction for this research is to be able to link healthcare 
costs for stroke and rehabilitation with clinical outcomes using different post-
acute treatment paradigms. Lastly, estimates of the marginal cost of other 
illnesses should be performed. Marginal cost of illness methodology is 
particularly important to use for chronic diseases. For example, in the case of 
diabetes, a chronic disease associated with a great deal of comorbidities over a 
long period of time, it is important to generate diabetes-related cost estimates 
compared with a well-matched control group to produce practical estimates of 
healthcare costs that are due to diabetes rather than other illness. 
7 CONCLUSIONS 
In the first part of this study, we used Medicare claims from patients with 
ischemic stroke in South Carolina in 1997 and 2004 to examine two important 
health policy issues related to cost control and cost estimation. We explore the 
differences in the proportion of outpatient rehabilitation services cost that fall over 
the cap enacted in the Balance Budget Act of 1997. We then examined if the cap 
resulted in a reduction in expenditures for stroke prior to and after outpatient 
rehabilitation caps were enacted. Next we looked at the effect of using a total 
cost approach versus a marginal cost method to estimate the first year cost of 
stroke and stroke rehabilitation. 
We found that the utilization of rehabilitation services after ischemic stroke 
rose sharply between 1997 and 2004. We also found that the BBA 1997 caps did 
constrain the proportion of individuals over the outpatient rehabilitation caps in 
1997 versus 2004 and that costs of rehabilitation services were similarly 
constrained but only if these outcomes were examined using Medicare Part B 
provider bills, not when facility costs were also included. 
Lastly, we found that using a marginal costing approach to estimate 
healthcare costs due to ischemic stroke was important in the Medicare 
population compared to using total average costing techniques, in order to 
accurately attribute healthcare costs to stroke. Indeed, the average total costing 
approach may be expected to inflate the estimated 2004 SC total cost due to 
stroke for Medicare patients by $3.6 billion, because this approach ascribes 
expenditures for comorbid conditions to stroke. 
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Healthcare policy makers should consider other approaches than capping 
for controlling costs, and be wary of burden of illness estimates that employ 
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APPENDICES 
A d' A M .QQen IX edicare Data Dictionary of Variables 
Variable List 
# Variable Label 
16 ADMD Date of Admission 
146 Adj_Sum_rehab_ Total Rehab Payments adjusted to 2004 
GEN_pmt dollars, General 
142 Adj_Sum_rehab_ Total Rehab Payments adjusted to 2004 
OT_pmt dollars, aT 
140 Adj_Sum_rehab_P Total Rehab Payments adjusted to 2004 
T_pmt dollars, PT 
144 Adj_Sum_rehab_S Total Rehab Payments adjusted to 2004 
LP_pmt dollars, SLP 
110 Adj_ Total_Charge Total Charges adjusted to 2004 dollars, Total 
s 
111 Adj_ Total_Paymen Total Payments adjusted to 2004 dollars 
ts 
150 Adj_ Total_Rehab_ Total Rehab Payments adjusted to 2004 
Carrier_pmt dollars, Carrier 
148 Adj_ Total_Rehab_ Total Rehaq. Payments adjusted to 2004 
pmt dollars 
122 Adj_rehab_pmt_a Total Rehab Payments adjusted to 2004 
mt_genCA dollars, General Carrier 
121 Adj_rehab_pmt_a Total Rehab Payments adjusted to 2004 
mt otCA dollars, aT Carrier 
120 Adj_rehab_pmt_a Total Rehab Payments adjusted to 2004 
mt_ptCA dollars, PT Carrier 
119 Adj_rehab_pmt_a Total Rehab Payments adjusted to 2004 
mt_slpCA dollars, SLP Carrier 
31 Aphasia Dichotomous variable 1 =has Aphasia code in 
SDx, O=no Aphasia code in SDx 
152 Carrier_aver_Cap Dichotomous indicator total rehab carrier 
charges over the cap, 1 =yes, O=no 
128 CharAFib Dichotomous variable 1 =has Afib code, 0 
otherwise 




# Variable Label 
126 CharDiab Dichotomous variable 1 =has Diab code, 0 
otherwise 
127 CharMI Dichotomous variable 1 =has MI code, 0 
otherwise 
129 Charhichol Dichotomous variable 1 =has Hi Chol code 
130 Charhypertens Dichotomous variable 1 =has Hypertension 
code, 0 otherwise 
133 CharlsScore Charlson Comorbidity Score 
134 Cohort Dichotomous variable 1 =1997 group, 2=2004 
Group 
17 DISD Date of Discharge 
114 DME zero Indicator of Durable Medical Equipment 
payment of zero 
12 DaysAI ive _yea rpo Continuous number of days alive in the year 
ststroke after stroke 
15 DeathDate Date of Death using middle of the month (15th) 
imputation 
13 Died_yearpoststro Dichotomous variable 1 =died in year post, 0= 
ke did not die in year post stroke 
32 Dysarthria Dichotomous variable 1 =has Dysarthria SDx 
code, O=no Dysarthria SDx code 
33 Dysphagia Dichotomous variable 1 =has Dyphagia SDx 
code, O=no Dysphagia SDx code 
115 HH zero Indicator of Home Health payment of zero 
34 Hemianopia Dichotomous variable 1 =has Hemianopia SDx 
code, O=no Hemianopia SDx code 
38 Hemiplegia Dichotomous variable 1 =has Hemiplegia SDx 
code, O=no Hemiplegia SDx code 
116 Hosp_zero Indicator of Hospital payment of zero 
20 Last follow date Last date in study (either end of follow-up year - -
or date of death) 
37 MemLoss Dichotomous variable 1 =has Memory Loss 
code, O=no Memory Loss code 
118 NH zero Indicator of Nursing Home payment of zero 
134 
Variable List 
# Variable Label 
36 Neglect Dichotomous variable 1 =has Neglect SDx 
code, O=no Neglect SDx code 
117 OP zero Indicator of Outpatient payment of zero 
21 PDx Primary Diagnosis Code 
(ICD-9_CM) 
132 Prior time max Number of maximum prior days available in 6 -
months before index date 
22 SDIAG1 Secondary Diagnosis Code 1 (ICD-9_CM) 
23 SDIAG2 Secondary Diagnosis Code 2 (ICD-9_CM) 
24 SDIAG3 Secondary Diagnosis Code 3 (ICD-9_CM) 
25 SDIAG4 Secondary Diagnosis Code 4 (ICD-9_CM) 
26 SDIAG5 Secondary Diagnosis Code 5 (ICD-9_CM) 
27 SDIAG6 Secondary Diagnosis Code 6 (ICD-9_CM) 
28 SDIAG7 Secondary Diagnosis Code 7 (ICD-9_CM) 
29 SDIAG8 Secondary Diagnosis Code 8 (ICD-9_CM) 
30 SDIAG9 Secondary Diagnosis Code 9 (ICD-9_CM) 
35 Senslmp Dichotomou~ variable 1 =has Sensory 
Impairment code, O=no Sensory Impaiment 
code 
2 Stroke Aim 2 group indicator variable, 1 =stroke case, 
O=control 
39 Stroke_Severity Categorical Stroke Severity Score 
145 Sum rehab GEN Total payments rehab, General - - -
pmt 
141 Sum_rehab_OT_p Total payments rehab, OT 
mt 
139 Sum_rehab_PT _p Total payments rehab, PT 
mt 
143 Sum rehab SLP Total payments rehab, SLP - - -
pmt 
108 Total_Charges Total charges over study time period 
151 Total_Over_Cap Dichotomous indicator total rehab charges 
over the cap, 1 =yes, O=no 
135 
VariabJe List 
# VariabJe Label 
109 Total_Payments Total payments over study time period 
153 Total_Payments_1 Total payments over study time period 
997 
149 Total Rehab Carri Total payments carrier files - -
er_pmt 
147 Total_Rehab_pmt Total payments rehab 
3 age_group Categorized Age Group 
4 ageaprox Continuous Age Approximation (set as central 
point of age group) 
8 black Indicator of black race 
113 carner zero Indicator of Carrier (Part B) payment of zero 
11 dd Categorized discharge disposition 
9 deathind Died during study, 1 =yes, O=no 
135 expi red _i n hosp Dichotomous indicator expired in hospital, 
1=yes,O=no 
1 id Study su bject identifier code 
18 los Hospital Length of Stay 
, 
6 male Indicator of male gender, 1 =yes, O=no 
44 num CA bills Number of bills, Carrier - -
59 num DME bills Number of bills, DME - -
62 num HH bills Number of bills, Home Health - - ~ 
95 num NH bills Number of bills, Nursing Home - -
80 num OP bills Number of bills, Outpatient - -
77 num_hosp_bills Number of bills, hospital 
137 num rehab CAbill Number of rehab bills, Carrier - -
s 
136 num rehab bills Number of rehab bills - -
43 pmt_amt_CA Payment amount, Carrier 
58 pmt_amt_DME Payment amount, DME 
61 pmt_amt_HH Payment amount, HH 
94 pmt_amt_NH Payment amount, NH 
136 
Variable List 
# Variable Label 
79 pmt_amt_OP Payment amount, OP 
76 pmt_amt_hosp Payment amount, Hospital 
41 prior_hasp Indicator of prior hospitalization, 1 = yes O=no 
40 prior_stroke Indicator of prior stroke, 1 = yes O=no 
7 race RACE 
138 rehab Indicator of any rehab, 1 = yes O=no 
68 rehab num ICD57 Number of rehab bills stemming from code -
1 ptHH_bilis 571, for PT HH 
101 rehab num ICD57 Number of rehab bills stemming from code - -
1 ptNH_bilis 571, for PT NH 
86 rehab num ICD57 Number of rehab bills stemming from code - -
1 ptOP _bills 571, for PT OP 
71 rehab num ICD57 Number of rehab bills stemming from code - -
20tHH bills 571, for OT HH 
104 rehab num ICD57 Number of rehab bills stemming from code - -
20tNH bills 571, for OT NH 
89 rehab num ICD57 Number of rehab bills stemming from code - -
2otOP bills 571 , for OT ,OP ,.. 
74 rehab num ICD57 Number of reh'ab bills stemming from code - -
3slpHH_bilis 571, for SLP HH 
107 rehab num ICD57 Number of rehab bills stemming from code - -
3slpNH_bilis 571 , for SLP NH 
... 
92 rehab num ICD57 Number of rehab bills stemming from code - -
3slpOP _bills 571, for SLP OP 
65 rehab num ICD57 Number of rehab bills stemming from code - -
genHH_bilis 571, for GEN HH 
98 rehab num ICD57 Number of rehab bills stemming from code - -
genNH_bilis 571, for GEN NH 
83 rehab num ICD57 Number of rehab bills stemming from code - -
genOP _bills 571, for GEN OP 
47 rehab_num_genC Number of rehab Carrier bills, General 
A bills 
53 rehab num otCA Number of rehab Carrier bills, OT - - -
bills 
137 





10 ' 'Label ~ # . Variable 
Iii 
% %'J % -~ Ii @' h" , % . 
50 rehab_num_ptCA_ Number of rehab Carrier bills, PT 
bills 
. 
56 rehab_num_slpCA Number of rehab Carrier bills, SlP 
'" bills -
67 rehab_pmt_amt_1 ClM PMT AMT -
f. CD571 ptHH 
.. 
100 rehab_pmt_amt_1 ClM PMT AMT - -
: ~ ". , 
.$ 
CD571ptNH 
85 rehab_pmt_amt_1 ClM PMT AMT -
CD571ptOP 
iJ> ,, 70 rehab_pmt_amt_1 ClM PMT AMT - -
t' CD5720tHH 
, ,N 
1031 rehab_pmt_amt_1 ClM PMT AMT 
~ -
CD5720tNH 
88 rehab_pmt_amt_1 ClM PMT AMT - -
'" CD572otOP 
73 rehab_pmt_amt_1 ClM PMT AMT -
CD573slpHH 
106 rehab_pmt_amt_1 ClM PMT ,AMT 
- -
~ CD573slpNH 
91 rehab_pmt_amt_1 ClM 'PMT AMT - -
ii, 
CD573slpOP 
~ 64 rehab_pmt_amt_1 ClM PMT AMT - -
CD57genHH 
., 
91'~ rehab_pmt_amt_1 ClM PMT AMT 
t' ". - -
# 
CD57genNH 
82 rehab_pmt_amt_1 ClM PMT AMT -
CD57genOP 
46 rehab_pmt_amt_g ClM PMT AMT 
" -enCA 
521 rehab_pmt_amt_ot ClM PMT AMT - -
i!J CA 
© 





# Variable label 
55 rehab_pmt_amt_sl ClM PMT AMT - -
pCA 
66 rehab_totchg_ICD ClM TOT CHRG AMT - - -
571 ptHH 
,,; 
99 rehab_totchg_ICD ClM TOT CHRG AMT - - -
571 ptNH 
84 rehab_totchg_ICD ClM TOT CHRG AMT - - -
571ptOP 
69 rehab_totchg_ICD ClM TOT CHRG AMT - - -
5720tHH 
102 rehab_totchg_ICD ClM TOT CHRG AMT - - -
5720tNH 
87 rehab_totchg_ICD ClM TOT CHRG AMT 
:) . .. ?i; - - -
572otOP 
72 rehab_totchg_ICD ClM TOT CHRG AMT - - -
573slpHH 
105 rehab_totchg_ICD ClM TOT CHRG AMT - - -
/ 
573slpNH 
90 rehab_totchg_ICD ClM TOT ~HRG AMT - - -
573slpOP 
63 rehab_totchg_ICD ClM TOT CHRG AMT - - -
57genHH 
'i' ,.. 
96 rehab_totchg_ICD ClM TOT CHRG AMT - - -
57genNH 
~ 
81 rehab_totchg_ICD ClM TOT CHRG AMT - - -
57genOP 
45 rehab_totchg_gen Total charges amount Carrier, General 
CA 
~ 
51 rehab_totchg_otC Total charges amount Carrier, aT 
A 
48 rehab _ totchg_ptC Total charges amount Carrier, PT 
A 
54 rehab_totchg_slpC Total charges amount Carrier, SlP 
A 
5 sex Gender , 
139 
Variable List 
# Variable Label 
14 stroke date Date of Stroke or index date (for control 
subjects) 
10 stroke date04 Date of Stroke in 2004 (if any) 
123 stroke date97 Date of Stroke in 1997 (if any) 
19 stus cd PTNT DSCHRG STUS CD - --
42 totch9_CA Total charges for carrier files 
57 totch9_DME totch9_DME 
60 totch9_HH ClM TOT CHRG AMT - - -
93 totch9_NH ClM TOT CHRG AMT - - -
78 totch9_0P ClM TOT CHRG AMT - - -
75 totch9_hosp ClM TOT CHRG AMT - - -
Appendix B.-Billing C,odes used to Identify Rehabilitation Services 
1997 HCPCS/CPT Rehabilitation Codes 
95831 Massage 
95851 Manual Therapy 
97010 Supervised application of hot or cold packs 
97012 Supervised application of traction 
97014 Supervised application of electrical stimulation 
97016 Supervised ~pplication of vasopneumatic devices 
97018 Supervised application of paraffin bath 
97020 Supervised application of microwave 
97022 Supervised application of whirlpool 
97024 Supervised application of diathermy 
97026 Supervised application of infrared 
97028 Supervised application of ultraviolet 
97032 Application of electrical stimulation 
97033 Application of iontophoresis 
97034 Application of contrast baths 
97035 Application "'of ultrasound 
97036 Application of hubbard tank 
97039 Application of unlisted modality 
97110 Therapeutic procedure 15 mins) 
97112 Neuromuscular reeducation 
97113 Aquatic therapy 
97116 Gait Training 
97122 Traction 
97124 Massage 
97139 Unlisted therapeutic procedure 
97150 Therapeutic Procedure (group) 
140 
141 
97250 Myofascial release/soft tissue mobilization 
97260 Manipulation 
97261 Manipulation each additional area 
97265 Joint mobilization 
97504 Orthotics fitting and training 
97520 Prosthetic training 
97530 Therapeutic activities, direct 
97535 (OT) Self carel home management training 
97537 (OT) Community/work re-intergration 
97542 Wheelchair management 
97545 Work hardening/conditioning (initial 2 hrs) 
97546 Work hardening/conditioning (additional 1 hr) 
97703 Checkout for orthotic/prosthetic use 
97750 Physical performance test or measurement 
97770 Development of cognitive skills 
97799 Unlisted physical medicine/rehabilitation service 
, ,. 
'i SLP Codes 
~ I t\ 
HeReS/CPT . Description , M 
92506 Evaluation or speech, language, voice, 
communication, etc. 
92507 Treatment of speech, language, voice, 
communication, etc. 
92508 Treatment of speech, language, voice, 
communication, etc. (group) 
92525 Evaluation of swallowing and oral function for 
feeding 
92526 Treatment of swallowing dysfunction and/or 
oral function for feeding 
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2004 Outpatient Provider HCPCS Codes with PT modifier 
:@ % ;:"{ 
HCPCS 
Ii! 
ICPT Frequency Descrjption 
95831 1 Muscle Testing 
95851 5 Range of Motion Measure 
97001 75 PT Evaluation 
97002 19 PT Re-evaluation 
97003 4 OT Evaluation 
97010 6 HotlCold Packs 
97012 63 Traction 
97022 3 Whirlpool 
97024 1 Diathermy 
97032 155 Electrical Stimulation 
97033 1 1 Iontophoresis 
97035 124 Ultrasound 
97036 1 Hubbard Tank 
97110 1163 Therapy Procedure 
97112 217 Neuromuscular Re-education 
, 
97116 82 Gait Tralnir)g 
97124 30 Massage 
97140 102 Manual Therapy 
97150 45 Therapy Procedure (Group) 
97530 206 Therapy Activities 
97535 36 Activity of Daily Living Training 
97542 2 Wheelchair Management 
97750 9 Physical Performance Test 
G0283 10 Electrical Stimulation 
Total 2370 
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2004 Coded as PT without Modifier Code 
97001 PT Evaluation 
97002 PT Re-Evaluation 
97110 Therapy Procedure 
97112 Neuromuscular Re-education 
97116 Gait Training 
2004 Outpatient HCPCS Codes with OT Modifier Code 
97003 17 OT Evaluation 
97004 3 OTRe-Evaluation 
97010 3 HoUCoid Packs 
97032 4 Electrical Stimulation 
97033 14 Iontophoresis 
97035 7 Ultrasound 
971 10 1 14 Therapy Procedure 
971 12 47 Neuromuscular Re-education 
97140 11 Manual Therapy 
97150 1 Therapy Procedure (Group) 
97530 33 Therapy Activities 
97533 3 Sensory Integrative Techniques 
97535 19 Activities of Daily Living Tra.ining 
A4556 1 Electrodes 
G0283 25 Electrical Stimulation 
Total 302 










Occu ational thera services er da 
Services of an OT in home health or 
hos ice 15 mins 
Services of an OT in home health or 
hos ice 15 mins 
Services performed by an OT in 
maintenance 15 mins 
OT, in the home, er diem 














Therapy Procedure (Group) 
Therapy Activities 
Cognitive skills development 
Sensory Integrative Techniques 
". 
Activities of Daily Living Training 
Work Reinte ration Trainin 
Wheelchair Mana ement 
Work conditioning or hardening (initial 2 
hrs 
Work conditioning or hardening 
additional 1 hr 
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2004 Out atient HCPCS Codes with SLP Modifier Code 
1 Evaluation Swallowing 
1 Flex Scope Swallowing 
8 Neurobehavioral Status Exam 
11 










Treatment of speech, lang., voice, 
comm., or aud. disorder 
Treatment of speech, lang., voice, 
comm., or aud. Disorder (group) 
Treatment of swallowing dysfunction 
Evaluation Swallowing 
Flex Scope Swallowing 
, 
Evaluation of .auditory rehabilitation 
status (1 hr) 
Evaluation of auditory rehabilitation 
status (15 mins) 
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